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SUMMARY
A method for. the purification of EPSP synthase of IS. coli K12 
has been developed. The purification procedure consisted of 
ammonium sulphate fractionation, ion-exchange chromatography 
and hydrophobic chromatography. The final step involved 
substrate elution from a phosphocellulose column. EPSP synthase 
was purified 843-fold and in 22% yield over the (NH^^SO^ 
fraction.
12. coli EPSP synthase has been shown to be a monomeric enzyme. 
The subunit M^ was estimated to be 49,000 by SDS PAGE, and 
native M^ values of 42,000 and 55,000 were determined by gel 
filtration. Kinetic parameters for E. coli EPSP synthase are 
reported. The enzyme was inhibited by the herbicide glyphosate, 
inhibition was competitive with respect to phosphoenolpyruvate.
EPSP synthase has also been purified from an overproducing 
strain, IS. coli AB2829/pKD501. The overproduced enzyme was 
purified 50-fold and in 30% yield over the crude extract 
fraction. EPSP synthase can be purified-in; milligram quantities 
from the overproducing strain.
The overproduced enzyme has been shown to be identical in its 
physical and kinetic properties to EPSP synthase purified from 
E. coli K12. The amino acid composition and N-terminal amino 
acid sequence of IS. coli EPSP synthase are reported.
Chemical modification of EPSP synthase by 3-bromopyruvate has 
been examined. Although substrate protection against 
inactivation was observed, bromopyruvate did not appear to be
an active-site-directed reagent for IS. coli EPSP synthase.
Phosphoserine aminotransferase has been purified from the 
overproducing strain, IS. coli AB2829/pKD501. The purification 
procedure was similar to that developed for EPSP synthase; 
(NH^^SO^ fractionation, ion-exchange chromatography and 
hydrophobic chromatography. The final step was ion-exchange 
chromatography on a mono-Q column. PSAT was purified 
approximately 7-fold over the crude extract fraction.
The subunit M of E. coli PSAT has been shown to be 39,000 and r —  ----
this enzyme appeared to be dimeric. The amino acid composition 
and N-terminal amino acid sequence of PSAT are reported. Some 
kinetic properties of this enzyme are also described.
CHAPTER 1 
INTRODUCTION.
1.1 Introduction
Bacteria, plants and fungi are able to synthesise aromatic 
compounds from simple intermediates derived from carbohydrate metabolism 
while other organisms must rely on exogenously supplied aromatic rings. 
The early steps in aromatic biosynthesis are common to all organisms 
that synthesise aromatic compounds. This common pathway, which 
consists of the seven step synthesis of chorismic acid (figure 1.1), 
is often called the shikimate pathway after the central intermediate, 
shikimic acid. Chorismate is the precursor for the synthesis of the 
aromatic amino acids and a host of other aromatic compounds (figure 1.2).
This thesis is largely concerned with studies on the enzyme 
5-enolpyruvylshikimate 3-phosphate synthase (EPSP synthase) of 
Escherichia coli. EPSP synthase is the sixth enzyme activity of the 
shikimate pathway (figure 1.1). It catalyses the addition of the 
enolpyruvyl moiety of phosphoenolpyruvate .to shikimate 3-phosphate 
and results in the formation of EPSP and inorganic phosphate.
This chapter provides an introduction to EPSP synthase and the 
shikimate pathway, and chapters 3, 4 and 5 describe studies on 
J2. coli EPSP synthase. Chapter 6 describes studies on phosphoserine 
aminotransferase of'IS. coli, the background to these studies is given 
at the beginning of chapter 6.
1.2 The shikimate pathway and aromatic amino acid biosynthesis.
The sequence of the steps and the intermediates in the biosynthesis 
of chorismate and the aromatic amino acids were elucidated using 
bacterial auxotrophs largely by the groups of Davis (1955) and 
Sprinson (1960).
The/
FIGURE 1.1 
The shikimate pathway.
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Utilisation of chorismate.
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The shikimate pathway (figure 1.1) is a major biosynthetic 
route to chorismate. The carbon atoms of chorismate are derived 
from one molecule of erythrose 4-phosphate and two molecules of 
phosphoenolpyruvate (PEP). The first committed step of aromatic 
biosynthesis is the conversion of erythrose 4-phosphate and PEP to 
the seven carbon compound, 3-deoxy-D-arabinoheptulosonate 7-phosphate 
(DAHP). DAHP is cyclised and transformed into chorismate in six 
further steps. The second molecule of PEP is incorporated in the 
sixth step of the shikimate pathway, that catalysed by EPSP synthase.
The seven steps of the shikimate pathway are common to the 
biosynthesis of the majority of aromatic compounds. However, after 
chorismate, the biosynthetic pathways diverge to give many different 
products (figure 1.2). Aromatic biosynthesis has been reviewed by 
Haslam (1974).
Separate pathways exist for the biosynthesis of each aromatic 
amino acid from chorismate (figure 1.3). in phenylalanine and 
tyrosine biosynthesis, chorismate is re-arranged to give prephenate 
which is then either oxidised or dehydrated to yield 4-hydroxyphenyl- 
pyruvate or phenylpyruvate respectively. The final step is 
catalysed by an aminotransferase and yields tyrosine or phenylalanine 
respectively. In some organisms, transamination precedes 
decarboxylation and arogenate is a precursor of phenylalanine and 
tyrosine.
Biosynthesis of tryptophan from chorismate requires five 
further steps. The first step is synthesis of anthranilic acid 
with loss of the enolpyruvyl group of chorismate. The other carbon 
atoms/
FIGURE 1.3
Biosynthesis of the aromatic amino acids from chorismate.
Enzymes:
CM chorismate mutase
PDH prephenate dehydrogenase
PDase prephenate dehydratase
ASI (8) anthranilate synthase catalytic subunit
ASH (G) anthranilate synthase glutaminase subunit
9 anthranilate phosphoribosyl transferase
10 phosphoribosyl anthranilate isomerase
11 indole glycerol phosphate synthase
12 tryptophan synthase step 1
13 tryptophan synthase step 2
Intermediates:
PRA phosphoribosyl anthranilate
CDRP (O-carboxyphenylamino)-l-deoxyribulose 5-phosphate
PRPP phosphoribosyl pyrophosphate
G3P glyceraldehyde 3-phosphate

.atoms of tryptophan are derived from phosphoribosyl pyrophosphate 
and serine (figure 1.3).
1.3 The organisation of the enzymes of the shikimate pathway.
Studies on the enzymolog.y of the shikimate pathway have tended 
to concentrate on bacteria and fungi, with IS. coli and the bread 
mould Neurospora crassa as examples because of the ease with which 
genetic studies can be carried out in these organisms. However, 
photosynthetic organisms have recently received more attention.
The organisation of the enzymes of the shikimate pathway in IS. coli, 
N. crassa and plants is striki ngly different (figure 1.4-).
Historically, the organisation of enzymes 2 to 6 of the 
shikimate pathway in N. crassa attracted attention by the discovery 
that the "genes" coding for these five enzymes were closely linked 
(Giles et al, 1967a). It was subsequently demonstrated that these 
activities were associated as a multifunctional enzyme, the arom 
enzyme complex of N_. crassa (Lumsden & Coggins, 1977; Gaertner & 
Cole, 1977). The arom enzyme complex consists of two identical 
165^000 polypeptides (Lumsden & Coggins, 1978). Thus steps 2 to 6 
of the shikimate pathway are catalysed by one polypeptide chain in 
_N. crassa. It appears probable that other species of fungi possess 
a similar enzyme complex (Ahmed & Giles, 1969). Genetic studies on 
Saccharomyces cerevisiae (de Leeuw, 1967) and Schizosaccharomyces 
pombe (Strauss, 1979) showed that these yeasts contain gene clusters 
which appear to be similar to the arom locus of N_. crassa. The AR01 
cluster of S^. cerevisiae has been cloned and appears to produce a 
polypeptide/
FIGURE 1.4
Structural organisation of the enzymes of the 
shikimate pathway and tryptophan biosynthesis.
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polypeptide of M 150,000 (Larimer et al, 1983).
In bacteria, the enzyme organisation is very different (figure 1.4). 
The genes coding for the shikimate pathway enzymes are widely 
scattered around the E. coli chromosome (figure 1.5; Pittard &
Wallace, 1966; Bachmann, 1983). It was demonstrated that enzyme 
activities 2 to 6 of the shikimate pathway were separable by density 
gradient centrifugation in several species of bacteria (Berlyn &
Giles, 1969) and not aggregated as these activities are in fungal 
species (Ahmed & Giles, 1969). Many of the separable EL coli enzymes 
have recently been purified to homogeneity (Frost et al, 1984;
Chaudhuri & Coggins, 1984 and unpublished results; Lewendon &
Coggins, 1983).
In many photosynthetic organisms, the organisation is of a yet 
different pattern. Plants appear to have separable enzymes with the 
exception that the enzymes catalysing steps 3 and 4 appear to occur 
as a complex (Berlyn et al, 1970; Boudet & Lecussan, 1974; Polley,
1978; Koshiba, 1979a). This complex has been shown to be a 
bifunctional enzyme complex in the moss, Physcomitrella patens 
(Polley, 1978) and in pea seedlings, Pisum sativum (M.S. Campbell, 
unpublished results). However, this type of enzyme organisation is 
not the rule for all photosynthetic organisms as Euglena gracilis, 
a green alga, contains an enzyme complex similar to the N. crassa 
arom enzyme complex (Patel & Giles, 1979).
The enzyme organisation of the tryptophan biosynthetic pathway 
is also shown in figure 1.H-, again different levels of enzyme 
organisation are found in EL coli, ]£. crassa and plants. It is 
evident that multifunctional proteins in aromatic amino acid bio­
synthesis are not limited to one organism or pathway.
FIGURE 1.5 
Genetic map of E,. coli.
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Pathway step Gene Enzyme encoded
1 aroF DAHP synthase (Tyr)
1 aroG DAHP synthase (Phe)
1 aroH DAHP synthase (Trp)
2 aroB DHQ synthase
3 aroD Dehydroquinase
4 aroE Shikimate dehydrogenase
5 Shikimate kinase
6 aroA EPSP synthase
7 aroC Chorismate synthase
1.4 The enzymes and genes of the shikimate pathway.
This section provides a brief summary of the information 
currently available on each of the shikimate pathway enzymes with the 
exception of EPSP synthase which is discussed in detail later.
E. coli and N. crassa are again the main examples used.
1.4.1 DAHP synthase.
Carbon flow into the shikimate pathway appears to be regulated 
by the first enzyme of the pathway, DAHP synthase. This enzyme 
catalyses the condensation of erythrose 4-phosphate and PEP.
an<i N.* crassa each contain three DAHP synthase isoenzymes 
(figure 1.4), the activity of each of these is regulated by feedback 
inhibition by one of the three aromatic amino acids (Brown, 1968; 
Nimmo & Coggins, 1981a). In E. coli, the amount of DAHP synthase 
activity is also regulated at the level of transcription (Herrmann,
1983). This pattern of DAHP synthase activity is not universal, 
Bacillus subtilis contains a single DAHP synthase which is inhibited 
by prephenate (Llewellyn et alt 1980). Plant DAHP synthases also 
appear to be feedback inhibited by aromatic amino acids although 
these systems have not been fully characterised (Herrmann, 1983).
The properties of many purified DAHP synthases have been reported. 
DAHP synthase (Trp) of N. crassa obeys a rapid-equilibrium ordered 
mechanism where PEP is the first-binding substrate.and DAHP the last 
product released (Nimmo & Coggins, 1981b). Salmonella typhimurium and 
EL coli DAHP synthases (Tyr) also obey sequential mechanisms with 
the same order of substrate binding (DeLeo et al, 1973; Schoner & 
Herrmann, 1976). EL coli DAHP synthase (Phe) appears to contain 
iron/
iron (McCandliss & Herrmann, 1978), this isoenzyme 'is ine*ctivctfceeL V><j 
EDTA as is DAHP synthase (Trj.) of N. crossa
(Nimmo & Coggins, 1981b).
The IS. coli aroG (Davies & Davidson, 1982) and aroF (Schultz 
et al, 1984) genes have been sequenced. These genes code for the 
phenylalanine- and tyrosine-sensitive DAHP synthases respectively, 
the amino acid sequences of these two proteins are 53% homologous 
(Schultz et al, 1984). The aroF gene occurs in an operon together 
with the tyrA gene which codes for the bifunctional enzyme chorismate 
mutase : prephenate dehydrogenase (figure 1.3; Wallace & Pittard, 
1967).
1.4.2 Dehydroquinate synthase.
•3-dehydroquinate (DHQ) synthase converts DAHP to DHQ. The 
mechanism of ring closure is unclear, catalytic amounts of NAD+ and 
a metal ion are required for activity (Srinivasan et al, 1963). The 
N. crassa arom complex DHQ synthase activity has been shown to be a 
zinc-dependent enzyme (J.M. Lambert, Boocock, M.R. & Coggins, J.R., 
unpublished results). DHQ synthases from mung bean, Phaseolus mungo 
(Yamamoto, 1980) and EL coli (Maitra & Sprinson, 1978; Frost et al, 
1984) have been purified, these enzymes are reported to require Cu++ 
and Co++ respectively for activity. DHQ synthase of JB. subtilis 
has also been purified, this enzyme occurs as part of a multienzyme 
complex together with chorismate synthase and a flavin reductase 
activity (Hasan & Nester, 1978c).
The EL coli aroB gene has been cloned and DHQ synthase purified 
from an overproducing strain of EL coli. DHQ synthase appears to be 
a monomeric protein of 40,000 to 44,000 (Frost et al, 1984).
The/ .
The nucleotide sequence of the aroB gene has been determined 
(G. Millar, unpublished results).
1.4.3 Dehydroquinase.
This enzyme catalyses the dehydration of DHQ to yield 3- 
dehydroshikimate thus introducing the first double bond of the 
aromatic ring system. Dehydroquinase has been purified from 
IS. coli K12 and an overproducing strain of Eh coli. It is a dimeric 
enzyme of subunit 29,000 (S. Chaudhuri & Coggins, J.R.,unpublished 
results). The Eh coli aroD gene has been cloned (Kinghorn et al,
1981) and the nucleotide sequence of this gene has been determined 
(Duncan, 1984).
As discussed in section 1.3, in plants dehydroquinase occurs in 
association with shikimate dehydrogenase, the next enzyme of the 
shikimate pathway. The purified dehydroquinase: shikimate dehydro­
genase of ]?. patens appears to be a single polypeptide of 48,GOO- 
49, 000 (Polley, 1978).
1.4.4 Shikimate dehydrogenase.
Shikimate dehydrogenase catalyses the reduction of 3-dehydro- 
shikimate to shikimic acid; this enzyme is specific for NADPH. 
Shikimate dehydrogenase has been purified to homogeneity from Eh coli, 
it appears to be a monomeric enzyme of 31,000 (Chaudhuri & Coggins, 
1984). The E. coli aroE gene has been cloned and the nucleotide 
sequence of this gene has been determined (I.A. Anton, unpublished 
results).
1.4.5 Shikimate kinase.
This enzyme catalyses the phosphorylation of shikimate to give 
shikimate/
shikimate 3-phosphate (Shik 3-P). Shikimate kinase has been 
partially purified from two plant species, P. mungo (Koshiba, 1979b) 
and Sorghum bicolor (Bowen & Kosuge, 1979). A shikimate kinase 
activity has been purified to homogeneity from 13. subtilis strain 168; 
it is a small polypeptide of 10,000 which is active only in 
association with the DAHP synthase: chorismate mutase complex found
in this strain (Huang et al, 1975).
Eh coli appears to contain two shikimate kinase isoenzymes as 
single step mutants lacking shikimate kinase activity could not be 
isolated and two different forms of shikimate kinase activity were 
resolved by ion-exchange chromatography (Ely & Pittard, 1979). The 
level of shikimate kinase activity in Eh coli appears to be under 
transcriptional control; there is some evidence that only one 
shikimate kinase isoenzyme is repressed (Ely & Pittard, 1979). The 
possible function of control of shikimate kinase activity in Eh coli 
is unclear.
1.4.6 EPSP synthase.
This enzyme catalyses the formation of EPSP from shik 3-P and 
PEP and will be discussed in detail in section 1.5.
1.4.7 Chorismate synthase.
Chorismate synthase catalyses the formation of the branch point 
intermediate, chorismic acid. Reduced flavin (FMN.or FAD) appears 
to be necessary for activity. Eh coli chorismate synthase requires 
a reduced flavin-regenerating system and an 0£ free atmosphere 
(Morell et al, 1967),this enzyme has been little studied. 13. subtilis 
and _N. crassa chorismate synthases have been purified to homogeneity, 
both/
both enzymes appear to be associated with a flavin reductase activity. 
The 13. subtilis enzyme occurs as part of a chorismate synthase : DHQ 
synthase : flavin reductase multienzyme complex (Hasan & Nester, 1981b, 
whereas N_. crassa chorismate synthase activity appears to occur as a 
bifunctional enzyme complex together with a flavin reductase activity 
(Boocock, 1983). Both of these flavin reductase activities appear to 
utilise NADPH as the reducing agent (Welch et al, 1974; Hasan & Nester, 
1981a; Boocock, 1983). The reduced- flavin requirement for chorismate 
synthase activity is not understood.
1.4.8 Catabolic dehydroquinase and quinate dehydrogenase.
If N. crassa is grpwn on quinate as a carbon source, enzymes 
necessary for the catabolism of quinate are induced. These enzymes 
are quinate (shikimate) dehydrogenase, a catabolic dehydroquinase 
and 3-dehydroshikimate dehydratase (figure 1.6). These enzymes are 
coded for by the qa-3, qa-2 and qa-4 genes (Chaleff, 1974). These 
three genes are part of the jja gene cluster of N_. crassa which 
consists of five structural and two regulatory genes (Tyler jet al,
1984).
Under conditions where the c[a gene cluster is induced, N. crassa 
contains two dehydroquinase activities (Giles et al, 1967b), the 
catabolic activity and the biosynthetic arom complex dehydroquinase 
(figure 1.6). The catabolic dehydroquinase has been purified to 
homogeneity (Hawkins et al, 1982; Chaudhuri & Coggins, 1981), this 
enzyme appears to be-a dodecamer of subunit 20,000 (Chaudhuri &
Coggins, 1981). The inducible quinate dehydrogenase has also been 
purified, it is a monomeric enzyme of 41,000. This enzyme activity 
•appears/
FIGURE 1.6
The catabolic quinate pathway and biosynthetic 
shikimate pathway of N. crassa.
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appears to be NAD+-dependent and can utilise shikimate although less 
well than quinate (Barea & Giles, 1978). The nucleotide sequences 
of the qa-2 and qa-3 genes have been determined (N.H. Giles & Co­
workers, unpublished results). Preliminary searches for sequence 
homology (Maizel & Lenk, 1981) indicated that the deduced amino acid 
sequence of quinate (shikimate) dehydrogenase may show some homology 
with the sequence of Eh coli shikimate dehydrogenase (I.A. Anton, 
unpublished results), however, no homology was detected between the 
catabolic dehydroquinase and the E. coli dehydroquinase amino acid 
sequences (K. Duncan, unpublished results).
NAD+-dependent quinate dehydrogenase activities have been 
detected in plants (Gamborg, 1967; Minimakawa, 1979) although it is 
not yet clear whether these enzymes play a biosynthetic or degradative 
role. Both free and esterified forms of quinic acid can be found in 
large amounts in many plant species. Zea mays appears to contain 
a quinate dehydrogenase that occurs as a complex with a dehydroquinase 
activity, this is probably not a universal situation (Graziana et al, 
1980). The activity of carrot cell quinate dehydrogenase has been 
reported to be controlled by reversible phosphorylation (Refeno et al,
1982) although the significance of this is not clear.
1.5 EPSP synthase : introduction.
EPSP synthase catalyses the reversible transfer of the
enolpyruvyl moiety of PEP to the 5-hydroxyl of shik 3-P to give
EPSP and inorganic phosphate (figure 1.7a; Levin & Sprinson, 1964). 
This type of reaction is somewhat unusual and only one other similar 
biosynthetic reaction is known. This is the condensation of UDPGlcNAc 
and/
FIGURE 1.7
(a) The reaction catalysed by EPSP synthase.
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(b) The reaction catalysed by UDPGlcNAc enolpyruvyl transferase.
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and PEP which is catalysed by the enzyme UDPGlcNAc enolpyruvyl 
transferase. This latter reaction is the first step of peptidoglycan 
biosynthesis (figure 1.7b; Gunetileke & Anwar, 1968). EPSP synthase 
and UDPGlcNAc enolpyruvyl transferase are distinct from other PEP- 
utilising enzymes in that they preserve the enolpyruvyl part of PEP 
(Davies, 1979). Because EPSP synthase catalyses an unusual reaction, 
the mechanism of this reaction has been studied' by a number of groups, 
particularly those of Sprinson (Bondinell et al, 1971) and Knowles 
(Grimshaw et al, 1982).
1.6 Aspects of the organisation of EPSP synthase.
EPSP synthase in IS. coli and other bacteria and in plants appears 
to be a separable, monofunctional enzyme (Berlyn & Giles, 1969;
Berlyn et al, 1970) whereas in jtf. crassa and other fungi, EPSP 
synthase is one of the activities of the pentafunctional arom enzyme 
complex (see figure 1.4; Lumsden & Coggins, 1977; Ahmed & Giles, 
1969).
There is evidence from genetic data and from protein studies 
that many multifunctional proteins are composed of domains, where 
each domain may correspond to one particular function of the multi­
functional protein (Kirschner & Bisswanger, 1976). .
Genetic studies of the _N. crassa arom gene cluster have 
elucidated the order of the enzyme activities along the polypeptide 
chain (Giles et al, 1967a; Rines et al, 1969). Figure 1.8 shows 
that mis-sense mutations which lead to the absence of one of the 
enzyme activities of the arom complex map in five discrete regions 
along the gene and therefore along the polypeptide chain. Further 
evidence in favour of a domain structure for the N_. crassa arom 
enzyme/
FIGURE 1.8
The arom locus of N. crassa.
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The unhatched areas on the.genetic map indicate that mis-sense 
mutations which lead to the absence of one of the enzyme 
activities of the arom complex.have been mapped in this area 
(Giles et_ al, 1967a; Rines et al, 1969). The enzyme activities 
are numbered as in figure 1.1. The mRNA and polypeptide 
products of the arom locus are shown. The approximate sections 
of the arom polypeptide which correspond to the EPSP synthase 
(E6) and dehydroquinase/shikimate dehydrogenase (E3/E4) 
fragments isolated after limited proteolysis of the arom 
complex (Boocock, 1983; Smith & Coggins, 1983) are indicated.
enzyme complex comes from studies involving limited proteolysis 
of pure arom complex. After limited proteolysis it has proved 
possible to isolate two non-overlapping fragments, one of which 
carries dehydroquinase and shikimate dehydrogenase activities 
(Smith & Coggins, 1983; Boocock, 1983), while the other carries only 
EPSP synthase activity. The EPSP synthase fragment has an of 
74,000 under denaturing conditions and appears to have a dimeric 
structure (Boocock, 1983).
The simplest model for the origin of multifunctional proteins 
must be that involving fusion of adjacent genes coding for mono­
functional proteins. There is good evidence from DNA sequencing 
studies that two multifunctional proteins of tryptophan biosynthesis, 
the bifunctional anthranilate synthase component II : anthranilate- 
5-phosphoribosylpyrophosphate phosphoribosyl transferase of 12. coli 
and the bifunctional tryptophan synthase of SL cerevisiae (figures 
1.3 and 1.4) have been produced by gene fusion (Miozarri & Yanofsky, 
1979; Zalkin & Yanofsky, 1982). The question of whether the fungal 
arom enzyme complexes have been produced by gene fusion is likely to 
be answered at the DNA sequence level. It is encouraging that many 
of the monofunctional IS. coli.genes have recently been sequenced 
(G. Millar, unpublished results; Duncan, 1984; I.A. Anton, unpublished 
results; Duncan et al, 1984b), and also that the arom gene clusters 
of SL cerevisiae and S^. pombe have been cloned (Larimer et al^ , 1983; 
Nakanishi & Yamamoto, 1984).
1.7 Glyphosate.
Interest in EPSP synthase has increased greatly since Amrhein
and/
and co-workers identified EPSP synthase as the site of action of the 
herbicide glyphosate (Amrhein et al., 1980; Steinrucken & Amrhein, 1980). 
Glyphosate (N-[phosphonomethyl] glycine; figure 1.9) is a broad- 
spectrum, post-emergence herbicide, it has low mammalian toxicity and 
is widely used in agriculture, glyphosate has been very successful 
commercially. Glyphosate was shown to interfere with aromatic bio­
synthesis (Jaworski, 1972), this inhibition was subsequently traced 
to inhibition of the shikimate pathway and EPSP synthase (Amrhein 
et al, 1980). It was demonstrated that EPSP synthase in extracts of 
Aerobacter aerogenes (= Klebsiella pneumoniae) was very sensitive to 
inhibition by glyphosate (Steinrucken & Amrhein, 1980).
Since then, a number of EPSP synthase activities have been shown 
to be sensitive to glyphosate inhibition. A detailed study of glyphosate 
inhibition of N_. crassa EPSP synthase has been reported, glyphosate 
was shown to be a competitive inhibitor with respect to PEP, that is, 
glyphosate appears to act as an analogue of PEP (Boocock & Coggins,
1983). Glyphosate has been reported to inhibit both bacterial 
(Anton et al, 1983; Duncan et al, 1984a; Steinrucken & Amrhein, 1984b) 
and plant (Amrhein et al, 1982; Mousdale & Coggins, 1984a; Rubin et al,
1984) EPSP synthases in the same manner.
Glyphosate inhibition of EPSP synthase is very specific, structural 
analogues of glyphosate do not inhibit EPSP synthase and glyphosate 
does not inhibit other PEP-utilising enzymes at concentrations 
similar to those required to inhibit EPSP synthase (Boocock, 1983; 
Steinrucken & Amrhein, 1984b).
1.8/
FIGURE 1.9
The structure of glyphosate.
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1.8 Studies on the mechanism of EPSP synthase.
1.8.1 Isotope exchange studies.
An addition-elimination mechanism was proposed for EPSP 
synthase by Levin & Sprinson (1964), such a mechanism is shown in 
figure 1.10. Addition of shik 3-P to C-2 of PEP yields a tetrahedral 
intermediate and elimination of phosphate gives EPSP. The findings 
of elegant isotope exchange studies that have been carried out on 
EPSP synthase are outlined below. Partially purified bacterial 
extracts were used as a source of EPSP synthase activity for these 
studies.
18(i) PEP labelled with 0 in the C-O-P position released essentially 
all the label during synthesis of EPSP, thus elimination of 
phosphate occurred with C-0 bond cleavage (Bondinell et alj 
1971).
2.(ii) EPSP synthesised in 1^0 was labelled, the label was equally 
distributed between the E and Z positions of the carboxyvinyl 
group. This indicated that a freely rotating methyl group is 
formed at C-3 of PEP during the course of the reaction. No 
incorporation of label into PEP was seen in the absence of 
shik 3-P (Bondinell et al, 1971).
(iii) PEP labelled with aH and/or 3H at C-3 was used to demonstrate 
that there is discrimination against heavy isotopes in both the 
addition and elimination steps of the reaction (Ife et al, 1976; 
Grimshaw et al, 1982).
(iv) Stereospecifically labelled [3-2H, 3H] PEP was used to 
synthesise EPSP, because of the observed discrimination against 
heavy isotopes (Grimshaw et al, 1982) the EPSP produced was 
also/
•FIGURE 1.10
An addition-elimination mechanism for EPSP synthase 
(Levin & Sprinson, 1964).
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also stereospecifically labelled. It was deduced that the 
addition and elimination steps have opposite stereochemical 
courses, i.e. if addition is syn, elimination is anti or vice 
versa (C.E. Grimshaw, Sogo, S.G., Copley, S.D. & Knowles, J.R., 
unpublished results).
The results of the isotope exchange studies are in agreement 
with the proposed addition-elimination mechanism (figure 1.10). It 
should be noted that this mechanism differs somewhat from the 
mechanisms of most other PEP-utilising enzymes, e.g. the pyruvate 
kinase, PEP carboxylase and PEP carboxykinase reactions proceed via 
cleavage of the 0-P rather than the C-0 bond at C-2 of PEP (Davies, 
1979). DAHP synthase (section 1.4.1) also cleaves the C-0 bond 
(DeLeo et al, 1973), however the mechanism of this reaction is different 
from that of EPSP synthase as it involves stereospecific addition of 
erythrose 4-phosphate to C-3 of PEP (Floss et al, 1972; DeLeo et al, 
1973).
Isotope exchange studies of Micrococcus 1j.gpdeikticus UDPGlcNAc 
enolpyruvyl transferase have shown that a freely rotating methyl group 
is formed during the course of this reaction- (Cassidy & Kahan, 1973).
The mechanisms proposed for UDPGlcNAc enolpyruvyl transferase, on 
the basis of substrate labelling experiments, involve the formation 
of an enzyme-PEP or enzyme-enolpyruvyl covalent intermediate 
(figure 1.11). Formation of the covalent intermediate requires the 
initial presence of UDPGlcNAc (Cassidy & Kahan, 1973; Zemell & Anwar, 
1975). A cysteine residue has been implicated in the formation of 
the enzyme-PEP covalent intermediate. UDPGlcNAc enolpyruvyl 
transferase is inactivated by the antibiotic fosfomycin owing tb covalent 
modification/
FIGURE 1.11
The covalent intermediate mechanism proposed for 
UDPGlcNAc enolpyruvyl transferase (Cassidy & Kahan, 1973; 
Zemell & Anwar, 1975).
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modification of a cysteine residue by this compound (figure 1.11). 
Fosfomycin was thought to act as a PEP analogue as inactivation 
required the prior binding of UDPGlcNAc (Kahan et al, 1974).
Fosfomycin appears not to inactivate EPSP synthase (Boocock, 1983; 
Steinrucken & Amrhein, 1984b), similarly glyphosate does not inhibit 
UDPGlcNAc enolpyruvyl transferase (Steinrucken & Amrhein, 1984b).
It has been pointed out that the isotope exchange studies on 
EPSP synthase do not rule out the possibility of a mechanism 
involving a covalent enzyme-PEP intermediate for this enzyme (Cassidy 
& Kahan, 1973; Ganem, 1978; Boocock, 1983). In an attempt to gather 
evidence for such an intermediate, Anton et al (1983) used 4, 5- 
dideoxyshikimate 3-phosphate as an analogue of shik 3-P. This group 
observed some exchange of the hydrogen atoms at C-3 of PEP with the 
solvent in the presence of partially purified EPSP synthase and 4, 5- 
dideoxyshikimate 3-phosphate. As yet, no reports of successful 
substrate labelling of EPSP synthase have appeared.
1.8.2 Steady-state kinetic studies.
Kinetic studies on N_. crassa EPSP synthase (Boocock, 1983;
Boocock & Coggins, 1983) and 1C. pneumoniae EPSP synthase (Steinrucken 
& Amrhein, 1984a, b) have been reported. Different kinetic mechanisms 
have been proposed for these EPSP synthase activities.
Detailed steady-state kinetics including inhibition by glyphosate. 
and the use of arsenate as a pseudo-substrate have led to the proposal 
of the following kinetic mechanism for N_. crassa EPSP synthase 
(Boocock, 1983; Boocock & Coggins, 1983).
(i) Shik 3-P is the first substrate to bind to EPSP synthase.
(ii) The enzyme*shik 3-P complex can bind either PEP or glyphosate.
(iii) Release of EPSP and phosphate from the enzyme is in random order. 
Glyphosate inhibition of EPSP synthase would be due therefore to 
formation of an enzyme#shik 3-P#glyphosate dead-end complex (Boocock 
& Coggins, 1983).
However, Steinrucken & Amrhein (1984a) have proposed a random 
sequential mechanism for IC. pneumoniae EPSP synthase in the forwards 
direction. In this case, glyphosate would inhibit EPSP synthase by 
binding to the free enzyme as well as to the enzyme#shik 3-P complex 
(Steinrucken & Amrhein, 1984b).
It is impossible to say whether the bacterial and fungal EPSP 
synthases do indeed have different kinetic mechanisms as rather different 
assay methods and conditions were used in each study (Boocock, 1983; 
Steinrucken & Amrhein, 1984a).
1.9 Introduction to E. coli EPSP synthase and the objectives of 
the present study.
When this study commenced, no purification scheme for a separable 
EPSP synthase had been reported, only the EPSP synthase activities 
of the arom enzyme complexes of ]N. crassa (Lumsden & Coggins, 1977) 
and E. gracilis (Patel & Giles, 1979) had been purified to homogeneity. 
The amount of information in the literature on separable EPSP synthases 
at that time was very limited.
It was decided therefore to purify and characterise a separable, 
monofunctional EPSP synthase. The source of separable EPSP synthase 
selected was IS. coli. Bacteria were easier to obtain than the other 
possible source of separable EPSP synthases, plant material. Plants 
also have the disadvantage that their extracts generally contain low 
protein/
protein concentrations. A factor behind the selection of IS. coli as 
a source of EPSP synthase was that Mr. K. Duncan in our laboratory 
was engaged in cloning and sequencing the gene coding for EPSP synthase 
(the aroA gene) from E. coli. Thus protein and DNA studies would 
complement each other.
It was known from genetic studies that IS. coli EPSP synthase 
was coded for by a single gene (Pittard & Wallace, 1966) and also 
that this gene was constitutively expressed (Tribe et al, 1976).
EPSP synthase activity had been first demonstrated in extracts 
of IS. coli where the reaction was shown to be reversible (Levin & 
Sprinson, 1964). Some characterisation of IS. coli EPSP synthase 
that had been purified 5-fold by ammonium sulphate fractionation was 
carried out. It was reported that the enzyme did not have any co­
factor requirements and that it was most active between pH5*4 and 
pH6:2. Michaelis constants for PEP and shik 3-P were reported to be 
0*24 mM and 0*34 mM respectively (Levin & Sprinson, 1964). The 
greatest degree of purification reported fora bacterial EPSP synthase 
was in the case of J5.‘ typhimurium EPSP synthase which was purified 
80-fold by (NH^^SO^ fractionation and ion-exchange chromatography 
(Bondinell et al, 1971). This 80-fold purified EPSP synthase was not* 
characterised but was used for mechanistic studies (section 1.8 .1).
The native of EPSP synthase activity in extracts-of EL coli had 
been estimated as 38,000 by sucrose density gradient centrifugation 
(Berlyn & Giles, 1969).
Therefore, the objectives of this study were:
1. To develop a purification procedure for EL coli EPSP synthase.
2. To characterise the purified enzyme as fully as possible.
•3./
To adapt the purification procedure so that large amounts of 
homogeneous, monofunctional EPSP synthase would be available 
for structural and mechanistic studies.
CHAPTER 2
MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals and biochemicals.
(tJq+  s a lt) (  s a K )(6 r « l«  I , N a  s a li)
Tris, Triethanolamine HC1 (TEA-HC1), ADfj, PEEj(, NADH, NADPH^raJeE,U<f 
idcljfrtt aci^ ) K /\ K
NAD"!, dithiothreitol (DTT) and phenylmethylsulphonyl fluoride
(PMSF) were obtained from Boehringer Corp. (London), Lewes, Sussex.
Wtfsatt) ( 'l i+s<xlt) (free acid)
FMNjf^  3-h^droxyp^ruvat^f, 3-phosphohydroxypyruvateJ, 3-phosphoserine|-jrre add),
3-bromopyruvatej(and bis-Tris (bis(2-hydroxyethyl)imino-tris-
(hydroxymethyl)methane) were obtained from Sigma(London) Chemical Co.,
Poole, Dorset.
MCI
Glutamate!, nitroblue tetrazolium, phenazine methosulphate and 
reagents for polyacrylamide gel electrophoresis (PAGE) were obtained 
from BDH Chemicals, Poole,Dorset.
All other reagents used were of the highest grade commercially 
available.
Glyphosate was a gift from Dr. S. Ridley, Plant Protection 
Division, ICI pic.
2.1.2. Chromatography media.
DEAE-Sephacel, Sephadex G-25 (medium grade), phenyl-Sepharose 
CL-4B and Sephacryl S200 superfine were obtained from Pharmacia (GB) Ltd., 
London, W5. Phosphocellulose (Pll) and DEAE-cellulose (DE52) were 
obtained from Whatman Biochemicals, Maidstone, Kent. Amberlite CG400 
was obtained from BDH Chemicals. Blue dextrqn Sepharose was a gift 
from Dr. S. Chaudhuri.
Pre-packed columns for gel filtration (TSK G2000SW and TSK G3000SW) 
were obtained from L.K.B. Ltd., South Croydon, U.K. A mono-Q (HR 5/5) 
column was obtained from Pharmacia (GB) Ltd, -the. n^o^o-Q. coLa^vo. is
c*- prgpo.cKecl- ou^ ton Colu.«v\
2.1.3/ J
rv
2.1.3 Enzymes and proteins.
The following enzymes were obtained from Boehringer Corp.: 
aldolase (EC 4.1.2.13) from rabbit muscle, 
alkaline phosphatase (EC 3.1.3.1) from calf intestine, 
carbonic anhydrase (EC 4.2.1.1) from bovine erythrocytes, 
catalase (EC 1.11.1.6) from beef liver, 
deoxyribonuclease I (EC 3.1.4.5) from bovine pancreas, 
glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12) 
from rabbit muscle, 
glutamate dehydrogenase (EC 1.4.1.3) from beef liver, 
isocitrate dehydrogenase (EC 1.1.1.42) from pig heart, 
lactate dehydrogenase (EC 1.1.1.27) from rabbit muscle, 
malate dehydrogenase (EC 1.1.1.37) from pig heart, 
3-phosphoglycerate kinase (EC 2.7.2.3) from yeast, 
pyruvate kinase (EC 2.7.1.40) from rabbit muscle.
The following proteins were obtained from Sigma Chemical Co.; 
horse heart cytochrome c , 
bovine serum albumin, 
chicken ovalbumin.
Staphylococcus aureus V8 protease was obtained from Miles,
Slough, U.K.
Bovine pancreatic trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.4. 
were obtained from Worthington Biochemical Corp., Freehold, New 
Jersey, U.S.A.)
2.1.4 E. coli and N. crassa.
(a) E. coli
E. coli/
_E. coli K12 was obtained from the American Type Culture collection,
catalogue number ATCC 14948/F , X tasoaeAvc cUrtV;ch\/<? K p - .> 
Lcderber^ W3lOO^.
E. coli AB2829/pKD501 (Duncan et al, 1984a) was obtained from
Mr. K. Duncan, Department of Biochemistry, Glasgow University.
JE.coll A52S21 (a x o k b S W- > A j su-j>ELflX a r u A .Acciy/aMve o|- _E_. coU Kli..
(b) N. crassa
N_. crassa strain 74-0R23-1A (F.G.S.C. No. 987) was obtained from 
the Fungal Genetics Stock Centre, Areata, CA, U.S.A. N. crassa 
was grown, harvested and stored as described by Lumsden & Coggins 
(1977).
2.1.5 Miscellaneous materials.
Coomassie Brilliant Blue G250 was from Serva Feinbiochemica, 
Heidelberg, West Germany. Nutrient broth was obtained from Oxoid, 
Basingstoke, U.K. Bacto-tryptone and yeast extract were from Difco, 
Detroit, Michigan, U.S.A.
2.2 General Methods
2.2.1 pH measurements.
The pH of solutions was measured using a Radiometer pH electrode 
at room temperature.
2.2.2 Conductivity measurements.
The conductivity of solutions was measured at 4°C using a 
Radiometer conductivity meter type CDM2e (Radiometer, Copenhagen,
Denmark).
2.2.3 Acid-washed glassware.
Glassware for protein chemistry was immersed overnight in conc. 
nitric acid, then rinsed extensively with water. The acid-washed 
glassware was dried by baking in an oven.
2.2.4/
2.2.4 Protein estimation.
Protein concentrations were determined by the method of 
Bradford (1976) using bovine serum albumin as standard.
2.2.5 Preparation of chromatography media.
Sephacryl S200, phenyl-Sepharose and DEAE-Sephacel were 
equilibrated with the appropriate buffer before use. DEAE-Sephacel 
was recycled by washing with 50 mM Tris-HCl pH7*5, 2M NaCl, and 
phenyl-Sepharose was recycled by washing with water.
DEAE-cellulo6e (DE52) was prepared as in the manufacturer's 
.instructions. Phosphocellulose was.pre-cycled by washing in dilute 
alkali and acid, de-fined and resuspended in either 10 mM potassium 
citrate pH6*0 (for EPSP synthase preparations) or 50 mM potassium 
phosphate pH6*5 (for chorismate synthase preparations). Phospho­
cellulose and DEAE-cellulose were discarded after being used once.
•2.3 Polyacrylamide gel electrophoresis.
The ratio of acrylamideibis-acrylamide in all PAGE experiments 
was 30:0*2. Polymerisation was induced by 0*03% (v/v) N,N,N7,N;- 
tetramethyl diamine and 0*05% ammonium persulphate.
2.3.1 Non-denaturing PAGE.
The discontinuous gel system of Davis (1964) was used, electro­
phoresis was performed at 4°C in 7% polyacrylamide tube gels. The 
gel buffer was 0*375 M Tris-HCl pH8*9 and the well buffer was 10 mM 
Tris/76 mM glycine, the upper well buffer contained 0*1 mM DTT. Gels 
were pre-electrophoresed for 1 h before enzyme samples were applied.
Samples for non-denaturing PAGE were mixed with 5 pi 0*05% (w/V) 
bromophenol blue and made 10% (v/v) glycerol if necessary before 
electrophoresis.
2.3.2/
2.3.2 SDS PAGE
SDS PAGE was carried out at room temperature as described by 
Laemmli (1970) in a slab gel apparatus (Raven Scientific Ltd., 
Haverhill, Suffolk). Slab gels were generally 20 cm x 15 cm x 1*2 mm. 
Separating gels were 10% or 15% polyacrylamide, the gel buffer was 
0*375 M Tris-HCl pH8 *8 , 0*1% SDS. Stacking gels were 3% polyacrylamide 
and the gel buffer was 0*125 M Tris-HCl pH6 *8 , 0*1% SDS. The well 
buffer was 25 mM Tris/190 mM glycine, 0*1% SDS.
Samples for SDS PAGE were prepared by adding an equal volume 
of 3% (w/v) SDS, 1% (v/v) 2-mercaptoethanol, 0*01% (w/v) bromophenol 
blue, 10% (v/v) glycerol. The samples were then heated for 2 min 
at 100°C prior to electrophoresis.
2.3.3 Staining.
(a) Protein staining
Unless otherwise stated, gels were stained for protein using 
Coomassie Brilliant Blue G250. Gels were immersed in 0*1% (w/v) 
Coomassie blue, 50% (v/v) methanol, 10% (v/v) acetic acid for 1 h 
at 40°C and then destained in 10% (v/v) methanol, 10% (v/v) 
acetic acid also at 40°C.
Gels were stained for protein by the silver method as described 
by Wray et^  al (1981) with some modifications. After'SDS PAGE, 
the gel was soaked for 2 to 3 d in 50% (v/v) methanol. The 
staining solution was prepared by adding 0*8 g AgNO^ dissolved 
in 4 ml water to 1*4 ml 14*8 M NH^OH and 21 ml 0*36% (w/v) NaOH 
with stirring, the volume was then increased to 100 ml with water. 
The gel was soaked in the staining solution for 15 min with 
gentle agitation, it was then rinsed with water and soaked in 
water/
water for at least 1 h with occasional agitation. The gel was then 
placed in developing solution which consisted of 2*5 ml 1% (w/v) 
citric acid and 250 jul 38% formaldehyde in 500 ml water.
Staining was stopped by transferring the gel to 10% (v/v) methanol, 
10% (v/v) acetic acid..
(b) Activity staining.
(i) EPSP synthase
The method of Nimmo & Nimmo (1982) was used to stain gels for EPSP 
synthase activity after non-denaturing PAGE. After electro­
phoresis, gels were soaked in 50 mM glycine-KOH pH10*0 for 30 min, 
and then transferred to 50 mM glycine-KOH pH10*0, 10 mM CaC^,
2 mM PEP, 1 mM shik 3-P. EPSP synthase activity was detected as 
a white band of precipitated calcium phosphate.
(ii) Phosphoserine aminotransferase
After non-denaturing PAGE gels to be stained for phosphoserine 
aminotransferase (PSAT) activity were soaked in 0*1 M Tris-HCl 
pH8#2 for 30 min to remove DTT. The gels were then transferred 
to staining solution which was kept in the dark. The staining 
solution contained 0*1 M Tris-HCl pH8*2, 12*5 mM 2-oxoglutarate,
0*6 mM nitroblue tetrazolium, 10 mM serine, 1 mM NAD+, 0*2 mM 
phenazine methosulphate and 48 units glutamate dehydrogenase 
per 8 ml staining solution. PSAT activity was detectable as a 
purple precipitate.
2.3.4 One-dimensional peptide mapping.
This was performed as described by Cleveland et_ al (1977). SDS 
PAGE was carried out as described in section 2.3.2 except that all 
gel solutions contained 1 mM EDTA.
The protein samples (approximately 2*5 f*g) for one-dimensional 
peptide/
.peptide mapping were contained in gel slices that had been cut out of a 
10% polyacrylamide SDS gel stained with Coomassie blue. The gel slices 
were soaked for 30 min in 0*125 M Tris-HCl pH6 *8 , 0*1% (w/v) SDS, 1 mM 
EDTA, and then pushed in to the wells of a 15% polyacrylamide SDS gel. 
The gel slices were first overlaid with 10 jul of the above buffer 
containing 20% (v/v) glycerol, and then with 10 jul of the same buffer 
containing 10% glycerol and protease. The protease concentrations were: 
jS. aureus V8 protease, 100 ; trypsin, 100 ml; chymotrypsin,
reached the bottom of the stacking gel to give time for proteolysis 
within the gel.
2.4 Preparation and standardisation of substrates.
2.4.1 EPSP synthase
Shik 3-P was isolated from culture filtrates of an Aerobacter 
aerogenes aromatic auxotroph, and was a gift from Dr. G.A. Nimmo. 
Shik 3-P was standardised by conversion to chorismate using EPSP 
synthase and chorismate synthase activities.
PEP was standardised by conversion to lactate using pyruvate 
kinase and lactate dehydrogenase.
EPSP was prepared enzymatically from shik 3-P and PEP using the 
N. crassa arom enzyme complex (3 units EPSP synthase activity in the 
reverse direction), and was purified essentially as. described by 
Knowles et al (1970). The purified barium salt was converted to 
potassium EPSP by the addition of a 5-fold excess of potassium 
sulphate. EPSP was standardised by conversion to chorismate using 
chorismate synthase activity.
The current was switched off for 30 min after the samples had
2.4.2 Phosphoserine aminotransferase.
Glutamate was standardised by conversion to 2-oxoglutarate using 
glutamate dehydrogenase. Treatment with alkaline phosphatase was used 
to convert 3-phosphohydroxypyruvate to 3-hydroxypyruvate, 3-hydroxypyruvate 
solutions were standardised by conversion to glycerate using lactate 
dehydrogenase.
2.5 Enzyme assays.
Spectrophotometric assays were performed at 25°C in a total 
volume of 1*0 ml. A Gilford Unicam SP500 spectrophotometer equipped 
with a Gilford photoelectric detector and recorder was used.
One unit of enzyme activity is defined as the amount of enzyme
catalysing the conversion of 1 umol of substrate per minute.
L i n e s  V \  k i n e t i c  f l o t s  u e r e  e u e -
2.5.1 EPSP synthase J
EPSP synthase was routinely assayed in the forwards direction 
by coupling to chorismate synthase. Chorismate (6275 = 2630 M-'*' cm 
Gibson, 1970) formation was monitored at 275 nm. The routine assay 
mixture contained 50 mM TEA*HC1-K0H pH7*0 } 50 mM KC1, 2*5 mM MgC^,
0*5 mM shik 3-P, 0*5 mM PEP, 20 juM NADPH, 10 j«M FMN and 8 m units 
partially purified- N. crassa chorismate synthase.
EPSP synthase was assayed in the reverse.direction by coupling 
the release of PEP to the pyruvate kinase and lactate dehydrogenase 
reactions. Oxidation of NADH (£3^  = 6200 M * cm was monitored 
at 340 nm. The assay mixture contained 100 mM potassium phosphate 
pH7-0, 2*5 mM MgCl2, 2*5 mM ADP, 0*1 mM NADH, 50 j*M potassium EPSP,
3 units pyruvate kinase and 2*5 units lactate dehydrogenase.
Unless otherwise stated, units of EPSP synthase activity quoted have 
been/
been determined using this assay procedure.
—  For kinetic studies of EPSP synthase in the-forwards direction, 
the assay mixture contained 50 mM bis Tris-HCl pH7*0, 50 mM KC1, 2*5 mM 
MgC^, 10 jiM FMN, 20 |*M NADPH, 10 m units partially purified N_. crassa 
chorismate synthase, PEP, shik 3-P and where appropriate, glyphosate.
In the reverse direction the assay mixture contained 50 mM bis Tris-HCl 
pH7*0, 50 mM KC1, 2*5 mM MgC^, 0*1 mM NADH, 2*5 mM ADP, 3 units 
pyruvate kinase, 2*5 units lactate dehydrogenase, phosphate and EPSP.
2.5.2 Phosphoserine aminotransferase.
This enzyme was routinely assayed by a modification of the method 
of Hirsch & Greenberg (1967) using 3-hydroxypyruvate and glutamate as 
substrates. PSAT activity was monitored at 340 nm by coupling the 
release of 2-oxoglutarate to glutamate dehydrogenase. The routine 
assay mixture contained 50 mM Tris-HCl pH8*2, 32 mM ammonium acetate,
2 mM glutamate, 2’5 mM 3-hydroxypyruvate, 0*2 mM NADH and 12 units 
glutamate dehydrogenase.
Modifications to this routine assay were introduced in order 
to assay PSAT activity with other pairs of keto acids/amino acids.
(i) To determine PSAT activity with other keto acids,
3-hydroxypyruvate was replaced with the appropriate substrate at 
a concentration of 1 mM.
(ii) Glutamate was replaced with 1 mM aspartate, and glutamate
dehydrogenase with 6 units malate dehydrogenase in order to 
determine PSAT activity with aspartate as an amino group donor; 
ammonium acetate was omitted.
PSAT was also assayed in the reverse direction with either serine 
or 3-phosphoserine as amino donor.
(i) serine: the assay mixture contained 50 mM Tris-HCl pH8‘2,
1 mM serine, 1 mM 2-oxoglutarate, 0*2 mM NADH and 2*8 units 
lactate dehydrogenase.
(ii) 3-phosphoserine: the assay mixture contained 50 mM Tris-HCl
pH8*2, 1 mM 2-oxoglutarate, 0*2 mM NAD+ and 60 units glutamate 
dehydrogenase.
2.5.3 Chorismate synthase.
N_. crassa chorismate synthase was assayed spectrophotometrically 
at 275 nm. The assay mixture contained 50 mM TEA*HC1-K0H pH7*0,
50 mM KC1, 2*5 mM MgCl2, 20 jiM NADPH, 10 jiM FMN and 50 jiM potassium 
EPSP.-
2.6 Growth of E. coli and preparation of cell extracts.
2.6.1 Media.
Minimal medium + glucose (MM + glc) consisted of M9 salts plus 
0*2% (w/v) glucose and 100 jaM CaC^.
M9 salts contained (per litre):
Na2HP04 6 g
KH2P04 3 g
nh4ci 1 g
MgS04 .7H20 0-13 g
Nutrient broth medium was 13 g oxoid nutrient broth per litre. 
L-Broth medium contained (per litre): 
bacto-tryptone 10 g
yeast extract 5 g
NaCl 10 g
and 0 *1% (w/v) glucose.
All media were sterilised by autoclaving.
E. coli were grown at 37°C, in 250 ml conical flasks, with shaking
on an orbital shaker unless otherwise specified.
2.6.2 Growth of E. coli K12.
EL coli K12 cells for enzyme preparations were grown by
B.A. Brodie, A.A. Coia and J. Greene.
Working stock cultures which had been grown in nutrient broth
were stored at 4°C.
Ik* coli K12 cells were grown as follows:
(i) Nutrient broth (50 ml) was inoculated with 2 or 3 drops of stock 
culture and grown overnight. It was then stored at 4°C for 
several hours.
(ii) A portion of this overnight culture (1 ml) was used to
inoculate 50 ml MM + glc, this second culture was then grown
overnight.
(iii) Then 8 flasks containing 50 ml MM + glc were inoculated with
1 ml of the overnight MM + glc culture, and grown for 8 h.
These cultures were stored at 4°C overnight.
(iv) Large scale growth of EL coli K12 was in 3 1 MM + glc in 10 1
flasks, each 3 1 of MM + glc was inoculated with 2 x 50 ml MM + 
glc cultures. The 3 1 cultures were stirred constantly by 
rotating bar magnets and compressed air was introduced to each 
flask at a flow rate of 400 ml/min. Growth of the large scale 
cultures was monitored at 420 nm, the cells were harvested in 
the late logarithmic phase of growth when the A ^ q  w^s between 
3*5 and 5*0 (the growth time was approximately 8 h).
(v) The cells were harvested by centrifugation at 6,000 g for 15 min
at 4°C. The pellets were resuspended in a minimal volume of
100/
100 mM Tris-HCl pH7*5, 0*4 mM DTT and stored at -20°C.
Typically, a yield of 25-30 g JL coli K12 cells (wet weight) was 
obtained from 12 1 MM + glc.
2.6.3 Growth of E. coli AB2829/pKD501.
The stock culture of EL coli AB2829/pKD501 was in L-Broth 
containing 40% (v/v) glycerol at -20°C.
EL coli AB2829/pKD501 cells were grown for enzyme preparation as 
follows:
(i) L-Broth (10 ml) containing 20 jag/ml tetracycline* was inoculated
with EL coli AB2829/pKD501 and grown overnight.
(ii) MM + glc (100 ml) was inoculated with 0*5 ml of the overnight 
L-Broth culture. This culture was grown for 8 to 10 h.
(iii) The. MM + glc culture was used to inoculate 18 x 500 ml batches
of MM + glc in 2 1 conical flasks to an A ^ q of 0*005. These
large scale cultures were grown for 11 to 15 h until the A ^ q of 
the cultures was between 1*3 and 1*5.
(iv) JL coli AB2829/pKD501 cells were then harvested and stored as 
described for EL coli K12 (section 2.6.2).
Approximately 20 g of EL coli AB2829/pKD501 were obtained from 
9 1 MM + glc.
2.6.4 Growth of E. coli for the preparation of 100,000 g supernatants. 
Both EL coli K12 and EL coli AB2829/pKD501 were grown as described
below for the preparation of 100,000 g supernatants.
(i) A 10 ml overnight L-Broth culture was grown up, in the case of
EL coli AB2829/pKD501 the culture contained 20 |ug/ml tetracycline.
(ii)/
(ii) MM + glc (100 ml) was inoculated with 0*5 ml of this overnight 
culture, this MM + glc culture was grown until the A^ ,-q was 
approximately 1*0 .
(iii) The cells were collected by centrifugation at 7,000 g for 15 min 
at 4°C, then resuspended in 100 ml 0*2 M Tris-HCl pH7*5, 0*2 M 
KC1, 0*4 mM DTT. The cells were again collected by centri­
fugation and resuspended in 5 ml of the above buffer. At this 
stage cells were either stored at -20°C overnight or sonicated 
immediately.
2.6.5 Cell breakage.
(a) Sonication and the preparation of 100,000 g supernatants.
Sonication was used to break cells for the preparation of 100,000 g
supernatants. A soniprobe type 1130 A (Dawe Instruments Ltd.) was 
used, sonication was at 3 amps for 3 x 30s with 30s rest intervals.
The soniprobe housing was kept cool during sonication using an ice- 
water slurry.
The sonicated cells were centrifuged at 100,000 g for 2 h at 
4°C, the supernatant was retained for enzyme assays.
(b) French pressure cell.
EL coli cells for enzyme purification (approximately 20 g wet 
weight) were resuspended to a final volume of 30 to 40 ml in 0*1 M 
Tris-HCl pH7*5, 1 mM EDTA, 0*4 mM DTT at 4°C. The cells were, 
broken by two passages through a French pressure cell at 8 tons/in2.
The body of the French pressure cell was cooled in ice prior to use. 
(The cell has a 1 in diameter piston with manual fill and a 
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capacity for 40 ml, Cat. no. J43398A, American Instruments Company, 
Silver Spring, Maryland, U.S.A.).
2.7 Enzyme Preparation.
All Tris-HCl buffers used during enzyme purification were 
prepared by dilution of a stock solution of 1 M Tris adjusted to 
pH7*5 with HC1 at room temperature. No further adjustment of pH- 
was made on dilution.
2.7.1 N. crassa arom enzyme complex.
The arom enzyme complex was purified by the method of Smith & 
Coggins (1983) as adapted by Lambert et al (Lambert, J.M., Boocock, 
M.R. & Coggins, J.R., unpaLlisted results).
2.7.2 N. crassa chorismate synthase.
Chorismate synthase was purified from 14. crassa for use as a 
coupling enzyme. The purification procedure was essentially that 
described by Boocock (1983), and is summarised in Table 2.1.
All steps were carried out at 0-4°C, and all buffers contained 
1*2 mM PM 5 F and 0*4 mM DTT unless otherwise specified.
1. Crude extract: N. crassa mycelia (100 g) were stirred for
1 h in 1*5 1 100 mM potassium phosphate pH7*0, 5 mM EDTA. The 
extract was centrifuged at 10,000 g for 30 min, the supernatant 
or crude extract was retained.
2. Negative DEAE-cellulose chromatography: The crude extract 
was pumped through a column (30 cm x 10 cm) of DEAE-cellulose 
(DE52) equilibrated in 100 mM potassium phosphate pH7*0. 
Chorismate synthase does not bind to DEAE-cellulose under 
these/
these conditions.
(NH^)qSO^ fractionation: The chorismate synthase pool from 
step 2 was fractionated with (NH^^SO^. The 40-50% saturated 
fraction was obtained, resuspended in 100 mM potassium phosphate 
pH7»0 and then dialysed overnight against 2 1 50 mM Tris-HCl 
pH7*5. The dialysed (NH^^SO^ fraction was centrifuged at
15,000 g for 15 min to remove precipitated protein.
4. DEAE-Sephacel chromatography: The 40-50% (NH^^SO^ fraction 
was subjected to ion-exchange chromatography on a column of DEAE- 
Sephacel (12 cm x 5 cm). Chorismate synthase was bound to 
DEAE-Sephacel in 50 mM Tris-HCl pH7*5, the column was washed 
with this buffer containing 30 mM KC1. A gradient of 30-300 mM 
KC1 in 50 mM Tris-HCl pH7*5 (total volume, 1 1) was applied to 
elute chorismate synthase activity.
5. Negative blue dextrqn Sepharose chromatography; The pool 
of chorismate synthase activity from step 4 was pumped through 
a column of blue dextran Sepharose (vol = 3 ml) equilibrated in 
50 mM Tris-HCl pH7*5, 50 mM KC1. Chorismate synthase does not 
bind to this column but the arom enzyme complex does, therefore 
N.' crassa EPSP synthase is removed at this step. Chorismate 
synthase was.dialysed against 2 x 2 1 10 mM potassium phosphate 
pH6 •5, 0-2 mM DTT, 0-6 mM PMSF.
6 . Phosphocellulose chromatography I: Chorismate synthase 
from step 5 was loaded on to a column of phosphocellulose
(25 cm x 1 cm) equilibrated in 10 mM potassium phosphate pH6*5, 
0*2 mM DTT, 0*6 mM PMSF, the column was washed with the same 
buffer./
buffer. Chorismate synthase was eluted with a gradient (total
volume, 400 ml) of 10 mM to 400 mM potassium phosphate pH6*5
containing 0*6 mM PMSF, 0*2 mM DTT. Chorismate synthase was
dialysed against 2 1 40 mM potassium phosphate pH6*5, 0*2 mM DTT.
7. Phosphocellulose chromatography II: Chorismate synthase
activity was loaded on to a column of phosphocellulose (vol = 3 ml)
equilibrated in 40 mM KP^ pH6*5, 0*2 mM DTT, the column was washed
with the same buffer. Chorismate synthase was eluted with a step
of 250 mM potassium phosphate pH6*5, 0*2 mM DTT, and then
SO'/, (v/v) glycerol,
dialysed against 50 mM Tris-HCl pH7*5,j^0*4 mM DTT and stored at 
-20°C.
.N. crassa chorismate synthase was purified 413-fold by this 
procedure and was free of activities that interfered with its use 
as a coupling enzyme.
2.8 Characterisation of EPSP synthase and phosphoserine amino­
transferase.
2.8.1 Performic acid oxidation and amino acid analysis.
Samples of EPSP synthase and PSAT were treated with performic 
acid (Hirs, 1967) prior to amino acid analysis.
The protein samples were extensively dialysed against 0*5% (w/v) 
ammonium bicarbonate at 4°C, and then lyophilised.
The performic acid reagent was prepared by mixing 95 volumes 
of formic acid with 5 volumes of 30% (w/v) ^ 02* this mixture was 
incubated at 25°C for 2 h. Lyophilised protein (approximately 1 mg) 
was resuspended in 420 jjil 70% formic acid plus 60 juil methanol. Both 
the protein sample and the performic acid reagent were cooled to 
between/
between -5 and 0°C, then 500 jul of reagent was added to the protein 
and incubation at -5°C was continued for 2*5 h. The reaction was 
stopped by adding 10 ml ice-cold water, and the sample was lyophilised.
Samples of performic acid oxidised protein for amino acid analysis 
(approximately 200 - 250 jutg) were hydrolysed in 500 jaI 6 N HC1, 0*1% 
(v/v) 2-mercaptoethanol in vacuo for 24, 48, 72 and 96 h at 105°C.
The samples were then lyophilised.
Duplicate analyses were carried out on an LKB 4400 amino acid 
analyser operated by Mr. J. Jardine at the Department of Biochemistry, 
University of Glasgow.
2.8.2 Carboxymethylation and protein sequencing.
(a) Carboxymethylation.
Carboxymethylation was carried out as described by Lumsden & 
Coggins (1978). Protein samples were dialysed against 0*5% (w/vj 
ammonium bicarbonate and then lyophilised. The lyophilised protein 
was resuspended in 2 ml 0*1 M Tris-HCl pH8*2, 8 M Urea, 2 mM DTT and 
incubated in the dark for 1 h at room temperature under an atmosphere 
of N2. The solution was then made 15 mM in iodoacetate and incubated 
for a further 1 h. The reaction was terminated by addition of DTT 
to a final concentration of 30 mM. The carboxymethylated protein 
was dialysed against 0*5% (w/v) ammonium bicarbonate and lyophilised.
(b) Protein sequencing.
The N-terminal amino acid sequences of carboxymethylated EPSP 
synthase and PSAT were determined using a Beckman Model 890 liquid 
phase sequencer (Smith et al, 1982) operated by Mr. B. Dunbar of 
Aberdeen University. The phenylthiohydantoin samples were analysed 
by/
by chromatography on a*Waters Resolve C18 reverse phase column with 
a pH5*0 acetate-acetonitrile buffer system (Carter et al, 1983).
Amino acid analysis after hydrolysis with HI (Smithies et al,
1971) was used to confirm doubtful residues.
The automatic protein sequencing was carried out on the SERC 
funded protein sequencing facility at Aberdeen University with 
assistance from Mr. B. Dunbar, Professor J.E. Fothergill and Dr.
L.A. Fothergill.
2.8.3 Molecular weight determinations.
Standard molecular weight proteins were taken from the list of 
proteins and enzymes given in section 2.1.3.
(a) Subunit M .
---------r
SDS PAGE (section 2.3.2) was used to determine the subunit Mf
of purified proteins. The proteins used to produce a standard curve
of R^ vs log M^ are listed below together with their subunit molecular 
weights (Weber & Osborn, 1969):
Protein Subunit M :--  ---------r
bovine serum albumin 68,000
catalase 60,000« 7
glutamate dehydrogenase 53,000
aldolase 40,000
glyceraldehyde 3-phosphate dehydrogenase 36,000
carbonic anhydrase 29,000
(b) Native M .--------r
Gel filtration was used to determine the native M^ of proteins.
Two different gel filtration media were used.
(i)/
(i) Sephacryl S200.
A column (56 cm x 1*1 cm) of Sephacryl S200 was equilibrated in 
50 mM Tris-HCl pH7*5, 50 mM KC1, 0-4 mM DTT at 4°C. The flow 
rate was 2*5 ml/h and 0*9 ml fractions were collected. The 
column void volume (Vq) was measured using blue dextran. The 
elution volumes (Vg) of proteins of known Mr were determined and 
a standard curve of Ve/VQ constructed. The standard proteins 
used to calibrate this column are listed below:
Protein
lactate dehydrogenase 
alkaline phosphatase 
malate dehydrogenase 
phosphoglycerate kinase 
cytochrome c
Hr Reference
144.000 Castellino & Barker, 1968
100.000 EngstrBm, 1961
70.000 Thorne & Kaplan, 1963
47.000 Krietsch & BUcher, 1970 
12,400 MargolCash et al, 1961.
(ii) HPLC gel filtration. A.Gilson model 305 and a. Miclarocn moctel
H300 variulle wavekndlh UV. detector were used, for HPlC y\. on,.
Both the TSK G2000SW and the TSK G3000SW gel filtration columns
(60 cm x 0*75 cm) were equilibrated with 0*067 M potassium
phosphate pH6*8 at room temperature. The flow rate was
0*5 ml/min and the column eluate was monitored at 215 nm.
The calibration proteins.for each column are listed below:
TSK G2000SW:
MProtein Reference
serum albumin
—r 
68,000 Tanford et al, 1967
ovalbumin 45,000 Castellino & Barker, 1963
carbonic anhydrase 29,000 Armstrong et al, 1966
myoglobin 17,200 Edmundson, 1965
TSK/
TSK G3000SW
• Protein M —r Reference
alkaline phosphatase 100,000 EngstrBm, 1961
serum albumin 68,000 Tanford et al, 1967
isocitrate dehydrogenase 61,000 Colman et al, 1970
phosphoglycerate kinase 47,000 Krietsch & BUcher, 1970
carbonic anhydrase 29,000 Armstrong et al, 1966
myoglobin 17,200 Edmundson, 1965
2.8.4 Chemical modification of EPSP synthase by 3-bromopyruvate.
Samples of EPSP synthase for chemical modification were desalted 
by HPLC gel filtration on a TSK G2000SW column equilibrated in the 
appropriate buffer (50 mM potassium citrate pH6*8 or 50 mM bis Tris- 
HCl pH6 *8, 50 mM KC1 or 20 mM Hepes-NaOH pH6 *8). Gel filtration was 
carried out essentially as described in section 2.8.3 except that the 
flow rate was 1 ml/min and the column eluate was monitored at 280 nm.
A fresh stock solution of 3-bromopyruvate (BrPyr) was prepared 
in the appropriate buffer. A portion of this BrPyr solution was 
added to a sample of EPSP synthase and this mixture was incubated 
at 25°C. Aliquots were removed at intervals and chemical 
modification was stopped by dilution (between 200-fold and 500-fold) 
into an assay mixture. The remaining EPSP synthase activity was then 
assayed immediately. The 100% value of EPSP synthase activity was 
obtained in a parallel experiment in which a sample of EPSP synthase 
was treated with substrates and/or inhibitors where appropriate, and 
a volume of buffer equivalent to the volume of BrPyr added in the 
chemical modification experiment. In all these experiments, EPSP 
synthase/
.synthase was assayed in the forwards direction by coupling to 
chorismate synthase; the assay buffer was 50mM bis Tris-HCl pH7*0, 
50 mM KC1, 2*5 mM MgC^ (section 2.5.1).
CHAPTER 3
THE PURIFICATION AND PRELIMINARY CHARACTERISATION 
OF EPSP SYNTHASE FROM E. COLI K12
3.1 Introduction
This chapter describes the simple and reproducible procedure that 
was developed for the purification of E. coli K12 EPSP synthase. Some 
properties of the purified enzyme are also described.
3.2 Purification Procedure
All steps m the purification procedure a f te r  cell breakage ucfC c a rrie d  o a t  a t 0
(a) Preparation of crude extract
IS. coli K12 cells (approximately 20 g) were passed two times through 
a French pressure cell as described in section 2.6.5. The broken cells 
were extracted with 60 ml of 100 mM Tris-HCl pH7*5, 0*4 mM DTT (buffer A) 
containing 1 mM EDTA, deoxyribonuclease I (0*5 mg) was added and the 
solution was stirred for 1 h. Centrifugation at 38,000 g for 30 min. 
produced a supernatant that was termed the crude extract.
(b) Ammonium sulphate fractionation
Solid (NH^^SO^ was added to the crude extract with stirring to 
give a final concentration of 291 g/1 (50% saturation). This solution 
was stirred for 30 min , then centrifuged at 23,000 g for 30 min. The 
pellet was discarded and solid (NH^^SO^ was added to the supernatant 
with stirring to give a final concentration of 416 g/1 (70% saturation). 
This solution was stirred for 30 min , and the precipitate was then 
collected by centrifugation at 23,000 g for 30 min. The precipitate 
was redissolved in a minimum volume of buffer A, and then dialysed 
overnight against .1 1 50 mM Tris-HCl pH 7*5, 50 mM KC1, 0*4 mM DTT 
(buffer B).
(c) DEAE-Sephacel chromatography
The dialysed 50-70% (NH^^SO^ fraction was loaded on to a column 
of DEAE-Sephacel ( 12. cm x E*? cm) equilibrated with buffer B. The 
column was washed with this buffer until the A£gQ of the eluate was 
l e s s /
less than 0*2; the flow rate was 70 ml/h and 6 ml fractions were 
collected. A gradient of 50 to 250 mM KC1 in 50 mM Tris-HCl pH7*5,
0*4 mM DTT (gradient volume, 400 ml) was applied to the column (see 
figure 3.1 for a profile). Fractions containing EPSP synthase 
activity were pooled and dialysed overnight against 1 1 buffer A.
(d) Phenyl-Sepharose chromatography
Solid (NH^^SO^ was added to the dialysed DEAE-Sephacel pool, 
with stirring to give a final concentration of 164 g/1 (30% saturation).
This solution was stirred for 15 min , and then loaded on to a column
of phenyl-Sepharose (12. cm x 2 cm) equilibrated with buffer A 
containing 0*8 M (NH^^SO^. The column was washed with a further 
100 ml of this buffer, then a gradient (total volume, 300 ml) of 0*8 
to 0 M (NH^^SO^ in buffer A was applied. The flow rate throughout 
was 70 ml/h and 6 ml fractions were collected (see figure 3.2 for a 
profile). Fractions containing EPSP synthase activity were combined 
and dialysed overnight against 2 x 2 1 10 mM potassium citrate pH6*0,
0-4 mM DTT (buffer C).
(e) Phosphocellulose chromatography
The dialysed enzyme was applied to a column of phosphocellulose 
(bed volume, 5 ml) equilibrated in buffer C, the column was washed with 
this buffer until the A2qq of the eluate was less than 0*01. The flow
rate was 7*2 ml/h and 2*4 ml fractions were collected. EPSP synthase
activity was eluted with buffer C containing 1 mM PEP and 1 mM shik 3-P 
(figure 3.3). Fractions containing EPSP synthase activity were pooled 
and desalted on a column (2 7 cm x t’S cm) of Sephadex G-25 equilibrated 
in buffer A. Solid (NH^^SO^ to a final concentration of 164 g/1 
(30% saturation) was added to the desalted enzyme which was then bound 
to/
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to a small column of phenyl-Sepharose (bed volume, 2 ml) equilibrated 
in buffer A containing 0*8 M (NH^^SO^. EPSP synthase was subsequently 
eluted with buffer A and dialysed against buffer B containing 50% (v/v) 
glycerol before storage at -20°C.
(f) Summary of purification procedure .
The results obtained from a typical purification procedure are 
shown in Table 3.1.
3.3 Purity
Non-denaturing PAGE of purified EPSP synthase showed a single band 
of Rf 0*48 (7% polyacrylamide gels) on staining for protein. This 
corresponded with a band of precipitated calcium phosphate on gels 
stained for EPSP synthase activity (figure 3.4). SDS PAGE of the 
purified enzyme also showed a single band on staining for protein 
(track E of figure 3.5).
3.4 Molecular weight
Measurements of native and subunit M were made in order tor
determine the quaternary structure of E. coli EPSP synthase.
The subunit M^ of the purified enzyme was determined by SDS PAGE. 
The mobilities of standard proteins of known subunit M^ were used to 
construct a standard curve of electrophoretic mobility against log 
subunit M^ (figure 3.6). Comparison of the mobility of EPSP synthase 
with these markers gave a subunit M^ of 49,000.
The native M^ of EPSP synthase was determined by gel filtration./^—  
Standard proteins of known M^ were used to calibrate a column of 
Sephacryl S200 and a standard curve of Ve/VQ against log Mr was 
constructed (figure 3.7). The measured ^e/VQ for EPSP synthase 
corresponded to an M^ of 55,000. Gel filtration produced identical 
values/
TABLE 3.2
Kinetic parameters of JL coli EPSP synthase
Substrate (co-substrate concentration)
PEP 15 jJiM (200 juM shik 3-P)
Shik 3-P 3*5 juM (500 f*M PEP)
Phosphate 2-5 mM (50 pM EPSP)
EPSP 2*5 jwM (50 mM phosphate)
Michaelis constants were determined at fixed concentrations
of co-substrates, the assay buffer was 50 mM bis Tris-HCl pH7*0,
50 mM KC1, 2*5 mM MgCl0 for all determinations. K values were° 2 m
derived from double reciprocal plots (e.g. Figure 3.9)3 “these 
Vq\ojZS \rl(LCl oWia-vrsecl '(roivv 5 \s \c j [& ‘ 'deterrwur\^ct»o^s . 
T)uplv code dete r  rw.d's O-t loios o|- l<M v&.Luz-S cl bsj
Hot *v\or£ 1  5 .
values of e^/^ Q f°r purified enzyme and for EPSP synthase activity in
100,000 g supernatants of E. coli K12 cell extracts.
The native of EPSP synthase was also determined by HPLC gel
filtration. A standard curve of Vg against log was constructed
from the Vg values measured for proteins of known (figure 3.8).
The measured Ve of E. coli EPSP synthase in this case corresponded
to an M of 42,000. r *
These results indicate that IS. coli EPSP synthase is a monomeric 
protein under the conditions used for the native molecular weight 
determinations.
3.5 Kinetic parameters
Michaelis constants for the substrates of the forward and
reverse EPSP synthase reactions were determined at fixed concentrations
of co-substrates. K^ values were estimated from double reciprocal
plots, typical plots are shown in figure 3.9 (a) and (b) from which
K values for PEP and phosphate were determined. The K values are m m
listed in Table.3.2.
The herbicide glyphosate was found to be a potent inhibitor of 
IS. coli EPSP synthase. The inhibition was competitive with respect 
to PEP (figure 3.10). A for glyphosate of l.OjuM was obtained 
under the conditions specified in the figure legend.
3.6 Discussion
A purification procedure has been developed that reproducibly 
gives homogeneous EPSP synthase from E. coli K12. This procedure 
consisted of four steps as outlined in Table 3.1. The-specific 
activity of EPSP synthase in the crude extract is not reported.
This/
This is because there are high blank rates of NADH oxidase activity in 
the E_;_ coli extracts which prevented accurate measurement of EPSP 
synthase activity. EPSP synthase activity can be determined in 100,000 g 
supernatants of E. coli extracts as the NADH oxidase activity sediments 
in this case. The specific activity in such an extract of E. coli K12 
was 0*006 units/mg of protein. The specific activity of EPSP synthase 
in the crude extract fraction is likely to be somewhat lower than this 
as some protein is undoubtedly removed through sedimentation.
The NADH oxidase activity was removed by the first step in the 
purification procedure, ammonium sulphate fractionation. EPSP synthase 
activity was located in the 50-70% saturation fraction. This activity 
was stable after (NH^^SO^ fractionation provided that 0*4 mM DTT was 
present in all buffers.
Three chromatographic steps were required to produce homogeneous 
enzyme. The first of these was ion-exchange chromatography on DEAE- 
Sephacel (figure 3.1). The major proportion of EPSP synthase eluted 
by a salt gradient was pooled, and subjected to hydrophobic chromatography 
on phenyl-Sepharose. JE. coli EPSP synthase bound to phenyl-Sepharose 
in 0*8 M (NH^^SO^ and was eluted in good yield by a decreasing gradient 
of (NH4)2S04.
The final step in the purification procedure involved substrate 
elution from a phosphocellulose column. Phosphocellulose has been 
reported to be an affinity chromatography medium for both the arom 
enzyme complex and chorismate synthase of N_. crassa (Cole & Gaertner, 
1975). A number of purification schemes reported for enzymes of the 
shikimate pathway include chromatography on phosphocellulose as one 
step in the procedure. Phosphocellulose has been used to purify the 
arom enzyme complex of N. crassa (Qaerlner & Cole. , 1976; Lumsden &
Coggins, 1977) and also chorismate synthase of 13. subtilis (Hasan &
Nester/
Nester, 1978b). Both these enzymes were eluted from phosphocellulose 
by an increase in phosphate concentration.
Substrate elution from phosphocellulose has been successful in the 
purification of two shikimate pathway enzymes other than IS. coli EPSP 
synthase. Homogeneous DAHP synthase (Trp) of If. crassa was eluted from 
phosphocellulose using PEP elution (Nimmo & Coggins, 1981a). PEP is the 
first substrate to bind to this enzyme which has been shown to have a 
rapid-equilibrium ordered mechanism (Nimmo & Coggins, 1981b). Chorismate 
synthase of N_. crassa has also been purified by a scheme that involves 
substrate elution from phosphocellulose. In this case, NADPH, FMN and 
either EPSP or chorismate are required for efficient elution of the 
enzyme (Boocock, 1983; A. Lewendon, unpublished results).
li. coli EPSP synthase differs from the above examples in that 
the enzyme will not bind to phosphocellulose in phosphate buffer, therefore 
potassium citrate buffer was used for the substrate elution step.
A lower pH (pH6*0 rather than pH6*5) was also required, however, EPSP 
synthase was quite stable under these conditions. The most useful 
method of substrate elution was with both PEP and shik 3-P in the eluting 
buffer. A step of phosphate (10 mM) eluted EPSP synthase as a peak of 
activity, but enzyme eluted in this way was not homogeneous. PEP 
applied alone did not elute EPSP synthase activity, shik 3-P alone 
did elute activity but as a very broad peak. A mixture of PEP and 
shik 3-P eluted a sharp peak of EPSP synthase activity (figure 3.3) 
that was homogeneous as judged by non-denaturing and SDS PAGE (figures
3.4 and 3.5). This elution pattern is consistent with an ordered 
mechanism in which shik 3-P is the first substrate to bind to EPSP 
synthase as has been demonstrated for the N. crassa EPSP synthase 
(Boocock & Coggins, 1983).
The/
The substrate elution step meant that it was necessary to remove 
substrates from the purified enzyme. EPSP synthase from phosphocellulose 
chromatography was desalted on a column of Sephadex G-25, the purified 
enzyme was concentrated on a small column of phenyl-Sepharose, followed 
by dialysis into buffer containing 50% glycerol. Purified EPSP synthase 
was stable for at least 4 months when stored at -20°C.
Figure 3.5 shows an SDS gel that monitors the purification at each 
.stage in this procedure. The specific activity of purified IS. coli EPSP 
synthase was 17*7 units/mg assayed in the reverse direction (phosphate 
assay buffer) and 62 units/mg when assayed in the forwards direction 
(triethanolamine assay buffer). EPSP synthase is purified 843-fold 
and in 22% yield over the (NH^^SO^ fraction (Table 3.1). If the 
specific activity of EPSP synthase in the crude extract is taken as 
0*006 units/mg, the total purification achieved is approximately 3000- 
fold. The yield of pure enzyme was 53 ^ g from approximately 20 g 
E. coli K12 cells.
This purification sckeme has proved useful in the purification of 
one other separable EPSP synthase, the enzyme from Pisum sativum has 
been purified to homogeneity by a very similar procedure (Mousdale & 
Coggins, 1984a).
Purification schemes for other bacterial EPSP synthases have recently 
been reported. Anton et al (1983) purified K. pneumoniae EPSP synthase 
more than 700-fold by (NH^^SO^ fractionation, DEAE-cellulose chromato­
graphy and gel filtration on Sephadex G-150. EPSP synthase was reported 
to be more than 90% pure after this procedure. Steinrucken & Amrhein 
(1984a) have purified IC. pneumoniae EPSP synthase to homogeneity by a 
six step procedure of (NH^^SO^ fractionation, a heat precipitation step, 
and/
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and chromatography on DEAE-cellulose, Sephadex G-75, phosphocellulose 
(where EPSP synthase was. eluted by a salt gradient) and finally chromato-
The specific activities reported for the other purified, mono­
functional EPSP synthases are compared with the specific activity of 
the E. coli enzyme in Table 3.3. The specific activity of EPSP synthase 
purified in this study compares favourably with the specific activities 
of the other purified enzymes, although differences in the assay 
conditions must be considered.
The values reported here indicate that 12. coli EPSP synthase is 
a monomeric enzyme. As EPSP synthase in relatively crude extracts of 
JE. coli K12 has the same native M^-as the purified enzyme, it is unlikely 
that quaternary structure is being lost during the purification procedure.
The different values determined for IS. coli EPSP synthase by 
gel filtration on Sephacryl S200 and by HPLC gel filtration on a TSK 
G2000SW column could be explained by differences in the properties of 
these gel filtration media. Discrepancies in M values obtained from these 
two types of column have been observed with other enzymes (Chaudhuri, S.
& J.R. Coggins, unpublished results). The fact that different sets of 
standard M proteins were used to calibrate each of these columns must 
also be considered.
The other separable EPSP synthases that have been purified to 
homogeneity also appear to be monomeric enzymes. Table 3.4 shows a 
comparison of native and subunit Mr values determined for the 
K. pneumoniae (Steinrucken & Amrhein, 1984a) and P. sativum (Mousdale & 
Coggins, 1984a) EPSP synthases. The estimates are rather similar 
for all three enzymes. values have been reported for several unpurified 
EPSP synthase activities, a number of bacterial EPSP synthases were 
shown/
TABLE 3.4
Molecular weights of purified EPSP synthases
Source
Subunit
Mr
Native
Mr Reference
E. coli K12 49,000 55.000
42.000
this study
P. sativum 50,000 44,000 Mousdale & Coggins 
(1984 a)
K. pneumoniae 43,000 32,400 Steinrucken & Amrhein 
(1984a)
M^ values determined for EL coli EPSP synthase are compared 
with the molecular weights reported for the two other monofunctional 
EPSP synthases to have been purified to homogeneity. All subunit 
values were determined by SDS PAGE, and all native values by 
gel filtration.
.shown to have molecular weights in the range 33,000 to 45,000 by sucrose 
density gradient centrifugation (Berlyn & Giles, 1969). The native Mr 
of partially purified EPSP synthase from mung beans, Phaseolus mungo 
(Koshiba, 1979a) and the fungus, Hansenula henricii (Bode & Birnbaum, 
1981) were reported to be 44,000 by gel filtration. All these Mr 
estimates are in the same range as the IT values determined for 12. coli 
EPSP synthase.
Michaelis constants for 15. coli EPSP synthase were determined 
using purified enzyme (Table 3.2). The Km values reported in this study 
are much lower than those reported previously by Levin & Sprinson (1964),
Glyphosate is a potent inhibitor of 15. coli EPSP synthase, 
inhibition is competitive with respect to PEP (figure 3.10). This type 
of inhibition has been reported for the EPSP synthases of N. crassa 
(Boocock & Coggins, 1983), .P. sativum (Mousdale & Coggins, 1984a) and 
IC. pneumoniae (Steinrucken & Amrhein, 1984b). 1L values for glyphosate 
for the IC. pneumoniae and N. crassa EPSP synthases (1 jjiM  and 1*1 julM 
respectively) are similar to that reported here for the E. coli enzyme 
(1*0 jdM). However, a KL of 80 nM was reported for the P. sativum EPSP 
synthase which therefore appears to be mor/e sensitive to glyphosate 
inhibition than the bacterial and fungal enzymes *
Further characterisation of EPSP synthase was limited by the 
rather small amounts of enzyme that could be readily purified from 
15. coli K12. This problem was solved by the use of a strain of 15. coli 
that contained elevated levels of EPSP synthase, the use of this strain 
is described in the next chapter.
however they used a bioassay procedure^ 
a t  £X of- G’/
: re/to assay EPSP synthase while
at a. pH «{- l-o
a sensitive coupled assay! was used in this study.
.FIGURE 3.1
Ion-exchange chromatography on DEAE-Sephacel.
The dialysed 50-70% (NH^^SO^ fraction was chromatographed on a column 
of DEAE-Sephacel as described in Section 3.2 (c). (°X ^ 280’
synthase activity; (d - 0 ), conductivity.
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FIGURE 3.2
Chromatography on phenyl-Sepharose.
Enzyme from chromatography on DEAE-Sephacel was subjected to 
chromatography on phenyl-Sepharose as described in Section 3.2 (d). 
(°)» A280; (#^EPSP synthase activity, (---- ), conductivity.
Fraction 
Number
NO
00
o
oro o-Cr OO') ooo
o
o
o
ro
o
— *
-Cr
o
o
o
o
o—
O')
. o-
ooo
oooooooo
oro oXT oCD o00 ro
EPSP synthase activity 
(units/ml)
O ’ o
VwAlO o
VJ1
o
Conductivity (mmho)
FIGURE 3.3
Chromatography of E. coli EPSP synthase on phosphocellulose.
Enzyme from chromatography on phenyl -Sepharose was loaded on to a 
column of phosphocellulose as described in Section 3.2 (e). The 
column was washed with buffer C and at the arrow buffer C containing 
1 mM PEP and 1 mM shik-3-P was applied. (o ^ ^ q q? (•), EPSP synthase 
activity.
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FIGURE 3.4
Non-denaturing PAGE of purified EPSP synthase.
Samples of purified EPSP synthase were subjected to non-denaturing 
PAGE (7% polyacrylamide gels) as described in Section 2.3.1. Gel A 
was stained for protein (2*2 jug loaded) and gel B was stained for EPSP 
synthase activity (28*3 m units).
A B
FIGURE 3.5
Purification of EPSP synthase from IS. coli K12.
SDS PAGE (10% gel) monitoring the purification of EPSP synthase from 
IS. coli K12. Track A, crude extract (200 jag protein); track B, 50-70% 
(NH^SO^ fraction (174 jag); track C, DEAE-Sephacel pool (35 fig); 
track D, phenyl-sepharose pool (4 fig); track E, enzyme after 
chromatography on phosphocellulose (3*4 ug).
A B C D E
FIGURE 3.6
Standard curve of R^ against log M^.
SDS PAGE (10% polyacrylamide gel) was carried out as described in 
Section 2.3.2. , the standard proteins (•) are listed in Section 2.8.3, 
the R^ of EPSP synthase is shown (o).
Log 
Molecular 
Weight
Relative Mobility
o  o  o  o
^  -Cr CT) 00
cn
00
•FIGURE 3.7
Standard curve of Ve/VQ against log M^.
A Sephacryl S200 column was calibrated with standard proteins (•) 
as described in Section 2.8.3. The Ve/VQ of IS. coli EPSP synthase 
is shown (o).
0.5-
^  0.3-
%
5.25.04.84.2
Log M o l e c u l a r  W e ight
FIGURE 3.8
Standard curve of against log NT.
An HPLC gel filtration TSK G2000SW column was calibrated with standard 
proteins (•) as described in Section 2.8.3. The Ve of EPSP synthase 
is shown (o).
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FIGURE 3.9
Double reciprocal plots of EPSP synthase.
(a) Double reciprocal plot of initial velocity against [PEP] at 
fixed 200 juM shik 3-P.
(b) Double reciprocal plot of initial velocity against [phosphate] 
at fixed 50 juM EPSP.
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FIGURE 3.10
Inhibition of E. coli EPSP synthase by glyphosate.
Double reciprocal plot of initial velocity against [PEP] at fixed 
200 jaM shik 3-P and glyphosate at (o), 0 jjM ; (•), 0*5 jxM;
(A), 1 fxM; (Jk), 2 jaM; (Q), 5 jiM.
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CHAPTER 4
PURIFICATION OF EPSP SYNTHASE FROM AN 
OVERPRODUCING STRAIN OF E. COLI
4.1. Introduction
Characterisation of 12. coli EPSP synthase was hampered by the 
limited amounts of homogeneous enzyme that could be readily purified 
from E. coli K12. This problem was solved by the cloning of the gene 
coding for EPSP synthase, aroA, from 12. coli (Duncan & Coggins, 1984).
Two obvious advantages result from cloning the gene coding for a 
protein of interest: the DNA sequence of the gene can be readily
obtained and it is possible to overproduce the protein. In the case 
of 12. coli EPSP synthase the cloned gene has been used to construct 
an overproducing strain (Duncan et al., 1984a) and recently the complete 
nucleotide sequence of the gene has been determined (Duncan et al., 
1984b).
E.coC KIX
subcloned from the transducing phage, ^ pserC 
(DUrtca/\ ITS1*).
{Ki fakaWQ&t al) on a 4*6kb Pst 1 fragment This fragment was inserted into 
the multicopy plasmid pAT153 (Twigg & Sherratt, 1980), and the
recombinant plasmid pKD501 (Duncan & Coggins, 1984) was used to transform
Ka .
an aroA strain of 12. coli^called AB2829 (Pittara & Wallace, 1966).
The transformed strain designated 12. coli AB2829/p K.D501 synthesised 
elevated levels of EPSP synthase (Duncan & Coggins, 1984). The 
insertion of cloned genes into vectors maintained at high copy number 
in 12. coli has been found to be a satisfactory method of overproducing 
proteins. .
This chapter describes the use of the overproducing strain,
12. coli AB2829/pKD 501, as a source of EPSP synthase, and protein 
chemical studies with the overproduced enzyme. The results of the 
protein chemistry are compared with data obtained from DNA sequencing 
studies (Duncan et al., 1984b).
The/aroA gene was firsl
4.2./
4.2. A comparison of the levels of EPSP synthase activity in E. coli
K12 and E. coli AB2829/p/CD501 
EPSP synthase activity was assayed in 100,000g supernatants of 
12. coli K12 and 12. coli AB2829/pKD501 cell extracts. The specific 
activities were 0*006 units/mg and 0*65 units/mg respectively (assayed 
in the reverse direction using the routine assay). E. coli AB2829/ 
pKD501 is clearly a good source of EPSP synthase; this strain over­
produces EPSP synthase by approximately 100-fold compared with 12. coli 
K12. This level of overproduction is consistent with the presence of 
the aroA gene on a plasmid that has a copy number of approximately 
100 per cell (Twigg & Sherratt, 1980).
4.3. Purification of EPSP synthase from E. coli AB2829/pKD501
The procedure was essentially that described in Chapter 3 for the 
purification of EPSP synthase from 12. coli Kl2. Modifications to the 
procedure are described below.
(a) Preparation of crude extract and (NH^)^SO^ fractionation
A crude extract was prepared from E. coli AB2829/pKD501 cells 
and the 50-70% (NH^^SO^ fraction obtained as described in section 
3.2. (a) and (b). The (NH^^SO^ fraction was dialysed against buffer B 
(2 1) overnight.
(b) DEAE-Sephacel chromatography
The dialysed (NH^^SO^ fraction was loaded on to a column of DEAE- 
Sephacel (15 cm x if-S'cm) equilibrated with buffer B. The column was 
washed with buffer B (2. to 3 column volumes), and then a gradient of 
50 to 250 mM KC1 in 50 mM Tris-HCl pH7*5, 0*4 mM DTT was applied 
(gradient volume 1000 ml). The flow rate throughout was 100 ml/h 
and 9 ml fractions were collected. An elution profile is shown in 
figure/
figure 4.1. Fractions containing EPSP synthase activity were combined 
and the pool dialysed against buffer A (1-1) overnight..
(c) Phenyl-Sepharose chromatography
This was carried out as described previously (section 3.2 (d)), 
except that the flow rate was 60 ml/h and 7*5 ml fractions were 
collected. Fractions containing EPSP synthase activity eluted from 
this column (figure 4.2) were pooled and dialysed against buffer C 
(3 x 2 1) for a total of 24 h.
(d) Phosphocellulose chromatography
The dialysed enzyme was loaded on to a column of phosphocellulose 
(10 cm x 2*Cm) equilibrated with buffer C and the column was washed 
with buffer C until the A^gQ of the eluate was less than 0*01. EPSP 
synthase was eluted with buffer C containing 1 mM shik 3-P and 1 mM 
PEP. An elution profile is shown in figure 4.3, the flow rate was 
10 ml/h and 3*3 ml fractions were collected during loading arid washing,
2 ml fractions were collected after application of the substrate elution 
buffer.
EPSP synthase eluted from the phosphocellulose column was 
concentrated by vacuum dialysis and then dialysed against buffer B 
containing 50% (v/v) glycerol before long term storage at -20°C.
4.4. Purity
EPSP synthase purified by this method was homogeneous as judged 
by giving one band on non-denaturing PAGE when slained for protein 
(figure 4.4 (a)) or EPSP synthase activity (not shown). Figure 4.5 
shows an SDS gel that monitors the purification of EPSP synthase from 
12. coli AB2829/pKD501, tracks D and E show homogeneous enzyme eluted 
from the phosphocellulose column. EPSP synthase appears to be the 
major component of the phenyl-sepharose pool (track C), this can be 
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compared with track C of figure 3.5.
Details of the purification of EPSP synthase from IS. coli AB2829/ 
pKD501 are given in Table 4.1. The enzyme was purified 50-fold over 
the crude extract in 30% yield. Homogeneous EPSP synthase from IS. coli 
K12 required 843-fold purification over the (NH^^SO^ fraction, this 
purification factor for EPSP synthase from the overproducing strain is 
only 26-fold. EPSP synthase can therefore be produced in milligram 
quantities from IS. coli AB2829/pKJ)501. In the typical preparation 
reported in Table 4.1, 4*8 mg of homogeneous enzyme was obtained from 
18 g of cells.
The specific activity of homogeneous, overproduced EPSP synthase 
of 21*1 units/mg is comparable with that of 17*7 units/mg for EPSP 
synthase purified from E. coli K12. The average specific activity of 
EPSP synthase purified from IS. coli AB2829/pKD501 was 21*9 units/mg 
(7 preparations).
4.5. Aggregation of EPSP synthase
After storage of purified, overproduced EPSP synthase for several 
weeks at -20°C, additional bands that stain for protein and EPSP 
synthase activity are visible after non-denaturing PAGE (figure 4.4(b)). 
The number of additional bands increased upon storage up to a maximum 
of three. Each additional band migrated more slowly than the previous 
one.
Gel filtration of this altered material on a TSK G2000SW column 
separated two peaks of protein, both of which coincided with peaks of 
EPSP synthase activity (figure 4.6 (a)). One of these peaks eluted at 
the same as newly purified EPSP synthase, the other peak eluted 
earlier indicating that this form of EPSP synthase had a higher 
molecular/
molecular weight. Thus the additional bands seen on non-denaturing 
PAGE are due to aggregation of EPSP synthase rather than some,other 
form of modification, e.g. proteolysis. This aggregation can be 
reversed by treatment of EPSP synthase with fresh reducing agent 
(1 mM DTT at 0°C overnight). After DTT treatment, both the 
additional bands on native gels and the higher species on gel 
filtration (figure 4.6 (b)) are absent.
Non-denaturing PAGE of 100,000 g supernatants of extracts of 
IS. coli AB2829/pKD 501 and IS. coli K12 showed only one band of 
precipitated calcium phosphate when stained for EPSP synthase 
activity (figure 4.4 (c) and (d)). EPSP synthase activity in extracts 
had the same mobility as freshly purified EPSP synthase. This 
indicates that this aggregation is unlikely to be the native state of 
IS. coli EPSP synthase.
As aggregation of EPSP synthase was reversed by the addition of 
fresh reducing agent, it seemed likely to be due to oxidation of 
sulphydryl groups and perhaps to intermolecular disulphide bridge 
formation. Aggregation appeared to occur only at high protein 
concentrations, no aggregation of IS. coli K12 EPSP synthase was 
observed even after storage for several months. The IS. coli K12 
enzyme was stored as more dilute solutions than the overproduced 
enzyme.
4.6. Evidence that EPSP synthases purified from E. coli K12 and
E. coli AB2829/pKD501 are identical.
(a) The homogeneous enzymes exhibit the same mobility on non­
denaturing PAGE, = 0*48 on 7% polyacrylamide gels.
(b) SDS PAGE of the overproduced and ’’wild-type1’ EPSP synthase 
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demonstrated that enzyme purified from both sources had the same subunit 
(figure 4.7).
(c) Limited proteolysis and one-dimensional peptide mapping (Cleveland 
et al., 1977) of enzyme isolated from each source was carried out as 
described in section 2.3.4. Preliminary experiments had shown that it 
was difficult to obtain similar levels of proteolysis unless the 
protein samples were digested under identical conditions. EPSP synthase 
to be ’’mapped’' was contained in slices cut out of an SDS gel. The 
protein samples were eluted electrophoretically into another SDS gel, 
and digestion occurred in the stacking gel of this second SDS gel. This 
ensured that both samples of EPSP synthase were digested under very 
similar conditions.
It proved difficult to digest EL coli EPSP synthase to give a 
number of readily separated fragments. Figure 4.8 shows one-dimensional 
peptide ’’maps” produced by digestion of EPSP synthase by three proteases 
of different specificity. The somewhat limited digestion patterns 
obtained for enzyme isolated from wild-type and overproducing EL coli 
are identical.
(d) Kinetic parameters for the overproduced EPSP synthase were 
determined. The values and the for glyphosate reported in
Table 4.2 for the EL coli AB2829/pKD501 enzyme are essentially identical 
to the kinetic parameters of the EL coli K12 enzyme. The ratio of the 
rates of the forward:reverse EPSP synthase reactions are also compared 
in Table 4.2, identical values are found for enzyme from both sources.
The structural and kinetic parameters of EPSP synthase purified 
from EL coli AB2829/pKD501 are therefore identical to the properties 
of the wild-type enzyme. Once this had been established, EL coli 
AB2829/pKD501 was used as a source of EPSP synthase and all 
experiments/
•experiments subsequently described in this thesis used enzyme purified 
from the overproducing strain.
4.7 Amino acid composition and N-terminal sequence of EPSP synthase.
(a) Amino acid composition.
The amino acid composition determined for EL coli EPSP synthase 
is shown in Table 4.3. The relative amino acid composition shown is 
based on 48 Leu residues per EPSP synthase. This composition can be 
easily compared with the amino acid composition derived from the DNA 
sequence of the aroA gene (Duncan et al., 1984b) which is also shown 
in Table 4.3. There is good agreement between the compositions derived 
at the protein and DNA levels.
(b) N-terminal sequence.
The N-terminal amino acid sequence of E. coli EPSP synthase was
determined by automatic protein sequencing of the intact protein. The
sequence is shown in figure 4.9, the sequence of residues 1 to 44 was 
determined before the build-up of background made unambiguous 
identification of PTH-amino acids impossible. AS PTH-His and PTH-Arg 
could not be definitely distinguished from each other by the HPLC 
analysis used, the assignment of residues 11, 27 and 36 was made by 
back-hydrolysis of the PTH-amino acids with HI (Smithies et al., 1971). 
Residues 1 to 12 were identified unambiguously, residue 13 could not 
be identified but back-hydrolysis showed that Asp was the most 
abundant amino acid present. The sequence was then unambiguous until 
residue 25 which could not be assigned, neither could residues 39 or 42. 
Residue 33 gave Ala:Val in a ratio of 2:1 and was tentatively assigned 
as Ala.
Figure 4.10 shows the DNA sequence of the EL coli aroA gene and
the/
TABLE 4.3
The amino acid composition of EL coli EPSP synthase compared with the 
amino acid composition deduced for EPSP synthase from the JL coli aroA 
gene sequence.
Amino acid
Relative amino acid 
composition based on 
Leu = 48 residues
Theoretical amino acid 
composition predicted from 
the DNA sequence
Asp 41-9 44
Thr 1 31-1 34
Ser 1 19-7 21
Glu 38-8 34
Pro 18-1 18
Gly 42*8 37
Ala 44-1 46
Cys 1 4*9 6
.. Val 21-7 24
Met3 13-6 14
H e 24*2 26
Leu 48*0 48
Tyr 13-1 13
Phe 13?2 13
His 8-1 8
Lys 17-0 17
Arg 17-2 22
Trp ND 2
^ Experimental values were extrapolated to zero time. - 
2
Determined as cysteic acid.
3 Determined as methionine sulphone.
Samples were analysed in duplicate after hydrolysis of performic 
acid oxidised-protein with 6M HC1 at 105°C for 24, 48, 72 and 96 h 
(section 2.8.1). The 8 experimental values were simply averaged 
except where indicated in the footnotes.
the corresponding amino acid sequence of EPSP synthase (Duncan et: al., 
1984b). If the N-terminal sequence (figure 4.9) is compared with this 
sequence, it is evident.that the sequence determined at the protein 
level agrees very well with that derived from the DNA sequencing 
studies, in fact, these sequences are identical for the first 22 
residues.
4.8 Discussion
The good agreement between the amino acid compositions determined 
at the protein and DNA levels indicates that the sequence shown in 
figure 4.10 comprises the complete EL coli aroA gene. The known 
N-terminal sequence allowed the translation start of the aroA gene to 
be located rapidly and unambiguously.
The predicted amino acid sequence of the EL coli aroA gene 
corresponds to a 427 amino acid polypeptide (figure 4.10), the M of 
EPSP synthase calculated from the deduced sequence is 46112 (Duncan 
et al., 1984b). This value is in good agreement with the values 
reported in Chapter 3 for EL coli EPSP synthase: the subunit M^ value
of 49,000 by SDS PAGE and the native Mr value of 42,000 by HPLC gel 
filtration.
The protein studies described here and the cloning and DNA 
sequencing studies carried out by Mr. K. Duncan in our laboratory have 
complemented each other. Cloning the aroA gene (Duncan & Coggins, 1984) 
meant that relatively large amounts of EPSP synthase became available. 
This in turn made possible the protein chemical studies which have 
allowed the unambiguous location of the coding sequence of the aroA 
gene on the sequenced DNA (Duncan el: al., 1984b).
FIGURE 4.1
Ion-exchange chromatography on DEAE-Sephacel.
The dialysed 50-70% (NH^^SO^ fraction was chromatographed on a 
column of DEAE-Sephacel as described in Section 4.3 (b). (o), A^gQ 
(•\EPSP synthase activity; (o-n), conductivity.
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FIGURE 4.2
Chromatography on phenyl-Sepharose.
Enzyme from chromatography on DEAE-Sephacel was subjected to chroma­
tography on phenyl-Sepharose as described in Section 3.2 (d). (.oX^gQ* 
(•), EPSP synthase activity; (o-o), conductivity.
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FIGURE 4.3
Chromatography on phosphocellulose.
Enzyme from chromatography on phenyl-Sepharose was loaded on to a 
column of phosphocellulose as described in Section 4.3 (d), the 
column was washed with buffer C. At the arrow, buffer C containing 
1 mM PEP and 1 mM shik 3-P was applied, and the fraction size was 
decreased from 3*3 ml to 2 ml. (o); (•), EPSP synthase activity.
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.FIGURE 4.4
Non-denaturing PAGE of EPSP synthase.
Non-denaturing PAGE (7% polyacrylamide gels) of samples of EPSP synthase 
was carried out as described in Section 2.3.1. Gels A and B were 
stained for protein, and gels C and D were stained for EPSP synthase 
activity (Section 2.3.3).
A. EPSP synthase purified from 12. coli AB2829/pKD501 (2. jug).
B. EPSP synthase purified from E. coli AB2829/pKD501 (18 jug), this
enzyme preparation had been stored for 7 weeks prior to 
electrophoresis.
C. EPSP synthase activity (0*46 m units) in a 100,000 g supernatant
of 12. coli K12 cell extract.
D. EPSP synthase activity (6*6 m units) in a 100,000 g supernatant
of 12. coli AB2829/pKD501 cell extract.

FIGURE 4.5
Purification of EPSP synthase from IS. coli AB2829/pKD501.
SDS PAGE (10% polyacrylamide gel) monitoring the purification of 
EPSP synthase from E. coli AB2829/pKD501. Track A, crude extract 
(104 jug protein); track B, 50-70% (NH^^SO^ fraction (68 jug); track C, 
DEAE-Sephacel pool (32 jug); track D, phenyl-Sepharose pool (7 JUg); 
tracks E and F, phosphocellulose pool (4 ug and 7*5 jmg).
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FIGURE 4.6
HPLC gel filtration of overproduced EPSP synthase.
HPLC gel filtration was carried out at room temperature on a 
TSK G2000SW column equilibrated in 50 mM bis Tris-HCl pH6 *8 .
The flow rate was 1*0 ml/min , 0*5 ml fractions were collected and • 
assayed for EPSP synthase activity. The column eluate was monitored 
at 280 nm with a full scale deflection equivalent to 0*1 absorbance 
units.
(a) 70 jyig of purified, overproduced EPSP synthase that had been stored 
at -20°C for 20 weeks.
(b) the sample was identical to (a) except that it had been 
incubated overnight at 0°C in the presence of 1 mM DTT.
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FIGURE 4.7
SDS PAGE of EPSP synthase purified from 12. coli K12 and E. coli 
AB2829/pKD501.
SDS PAGE (15% polyacrylamide gel) of wild-type and overproduced 
EPSP synthase. This gel was stained for protein using the silver 
method.
A. 12. coli K12 EPSP synthase (0*3 jig).
B. IS. coli AB2829/pKD501 EPSP synthase (0*7 jag).

FIGURE 4.8
One-dimensional peptide maps of EPSP synthase purified from IS. coli 
K12 and E. coli AB2829/pKD501.
Samples of EPSP synthase (2*5 jag) were contained in bands cut out of 
a 10% polyacrylamide SDS gel. Limited proteolysis occurred during 
electrophoresis through the stacking gel of a 15% polyacrylamide SDS 
gel as described in Section 2.3.4. This gel was stained for protein 
by the silver method (Section 2.3.3).
A. E. coli K12 EPSP synthase + chymotrypsin.
B. 12. coli K12 EPSP synthase + trypsin.
C. 12. coli K12 EPSP synthase + IS. aureus V8 protease.
D. 12. coli AB2829/pKD501 EPSP synthase + chymotrypsin.
E. 12. coli AB2829/pKD501 EPSP synthase + trypsin.
F. 12. coli AB2829/pKD501 EPSP synthase + S.* aureus ,V8 protease.
A B C D E F
FfSi/RE 4.9
The N-terminal amino acid sequence of E. coli EPSP synthase.
i 10
Met - Glu - Ser - Leu -Thr - Leu - Gin - Pro - lie - Ala -
11 20
Arg - Val - (-) - Gly - Thr - lie - Asn - Leu - Pro - Gly -
21 30
Ser - Lys - Ser - Val - (-) - Asn - His - Ala - Leu - Leu -
31 40
Leu - Ala Ala - Leu - Ala - His - Gly - Val - (-) - Val -
41 44
Leu - (-) - Asn - Leu -
The sequence was determined on a liquid phase sequencer as 
described in section 2,8.2. The initial amount of protein 
sequencing was 19 nmol and the repetitive yield from residue 
1 to 44, by least square regression analysis was 93% 
(correlation coefficient 0*95).
CoAtmuei over.
FIGURE 4.9 (continued)
Sequence PTH-amino nmoles back
number acid recovered hydrolysis
1 Met . 15*8
2 Glu 18-9
3 Ser 3-7
4 Leu 19*6
5 Thr 4-4
6 Leu 11*6
7 Gin 13*3
8 Pro 8*8
9 H e  7-4
10 Ala 13*0
11 Arg/His 9*2 Arg
12 Val 7-5 .
13 - Asp
14 Gly 7*4
15 Thr 3-1
16 H e  5-3
17 Asn 11*1
18 Leu 5*6
19 Pro 5*6
20 Gly 9-1
21 Ser -
22 Lys 4-5
23 Ser 0*8
24 Val • t 3-2
25
26 Asn 4*9
27 His/Arg ■ 3*4 His
28 Ala 4*0
29 Leu 4*1
30 Leu 2-9
31 Leu 3-8
32 Ala 1*8
33 Ala + Val 3-1 + 1*7
34 Leu 1*0
35 Ala 1*8 .
36 ?His/Arg - His
37 Gly 1-0
38 Val 1*6
39 - -
40 Val 0*8
41 Leu 1*1
42
43 Asn 1 • 1
44 Leu 1•1
-FIGURE 4.10
The E . coli aroA gene.
The complete nucleotide sequence of the IS. coli aroA gene and the 
corresponding amino acid sequence of IS. coli EPSP synthase. 
Nucleotides are numbered in the 5’ to 3’ direction beginning with the 
first residue of the ATG triplet encoding the N-terminal methionine. 
The bracketednumbers refer to the amino acid positions in the 
sequence. This sequence is taken from Duncan et al (1984b).
MET GLU SER LEU THR LEU GLN PRO I L E  ALA 
A T G G A A T C C C T G A C G T T A C A A C C C A 7 C G C T  
[ l ]  10 2 0  30
SER LYS THR UAL SER ASN ARG ALA LEU LEU 
J C C A A G A C C G / T T T C T A A C C G C G C T T T A T T G  
[2 1 ] 70  8 0  90
ARG VAL ASP GLY THR IL E  ASN LEU PRO GLY 
C G T G T C G A T G G C A C T A T T  A A T C T G C C C G G T  
4 0  5 0  4 0
L EU ALA h LA  L EU AL A HI S  GLY L YS THR VAL 
c r G G C G G C A T T A G C A C A C G G C A A A A C A G T A  
100  H O  1 20
LEU THR ASN LEU LEU ASP SER ASP ASP VAL ARG H I S  MET LEU ASN ALA L EU THR A LA - LEU 
T T A A C C A A T C T G C T G G A T A G C G A T G A C G T G C G C C A T A T G C T G A A T G C A T T A A C A G C  G-X t  a  
[4 1 ] '  1 3 0 ' 1 40  1 50  160  1 7 0  1 8 0
GLY VAL SER TYR THR LEU SER ALA ASP ARG THR ARG CYS GLU IL E  IL E  GLY ASN GLY GLY 
G G G G T A A G C T A T A C G C T T T C A G C C G A T C G T A C G C G T T G C G A A A T T A T C G G T A A C G G C G G T  
[6 1 ] 1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
PRO LEU H IS  ALA GLU GLY ALA LEU GLU LEU PHE LEU GLY ASN ALA GLY THR A LA  MET ARG 
C C A T T A C A C G C A G A A G G T G C C C T G G A G T T G T T C C T C G G T A A C G C C G G A A C G G C A A T G C G T  
[8 1 ]  2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
PRO LEU ALA ALA ALA LEU CYS LEU GLY SER ASN ASP IL E  VAL LEU THR GLY GLU PRO ARG 
C C G C T G G C G  G C A G C T C T T T G T C T G G G T A G C A A T G A T A T T G T G C T G A C C G G T G A G C C G C G T  
[1 0 1 ] 3 1 0  3 2 0  3 3 0  3 4 0  ,  . 3 5 0  3 6 0
MET LYS GLU ARG PRO IL E  GLY H IS  LEU VAL ASP A LA LEU ARG LEU GLY GLY A LA LYS IL E  
A T G A A A G A A C G C C C G A T T G G T C A T C T G G T G G A T G C G C T G C G C C T G G G C G G G G C G A A G A T C  
[1 2 1 ] 3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0
THR TYR LEU GLU GLN GLU ASN TYR FRO PRO LEU ARG LEU GLN GLY GLY PHE THR GLY GLY 
A C T T A C C T G G A A C A A G A A A A T T A T C C G C C G T T G C G T T T A C A G G G C G G C T T T A C T G G C G G C  
[ f  41 ]  4 3 0  4 4 0  -4 5 0  4 6 0  4 7 0  4 8 0
ASN VAL ASP VAL ASP GLY SER VAL SER SER GLN PHE LEU THR ALA LEU LEU MET THR ALA 
A A C G T T G A C G T T G A T G G C T C C G T T T C C A G C C A A T T C C T C A C C G C A C T G T T A A J G A C T G C G  
[1 6 1 ] 4 9 0  5 0 0  5 1 0  5 2 0  5 3 0  5 4 0
PRO LEU ALA PRO GLU ASP THR VAL IL E  ARG IL E  LYS GLY ASP LEU VAL SER LYS PRO TYR 
C C T £ T T G C G C C G G A A G A T A C G G T G A T T C G T A T T A A A G G C G A T C T G G T T T C T A ' A A C C T T A T  
r 1811 5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0
IL E  ASP IL E  THR LEU ASN LEU MET LYS THR 
A T C G A C A T C A C A C T C A A T C T G A T G A A G A C G  
[2 0 1 ] 6 1 0  6 2 0  6 3 0
GLN GLN PHE VAL VAL LYS GLY • GLY GLN SER 
C A A C A A T T T G T C G T A A A A G G C G G G C A G T C T  
[2 2 1 ] 6 7 0  6 8 0  6 9 0
PHE GLY VAL GLU IL E  GLU ABN GLN H IS  TYR
T T T G G T G T T G A A A T T G A A A A T C A G C A C T A T  
6 4 0  6 5 0  •  6 6 0
TYR- GLN SER PRO GLY THR TYR LEU VAL GLU
T A T C A G T C T C C G G G T A C T T A T T T G G T C G A A  
7 0 0  7 1 0  7 2 0 .
GLY ASP ALA SER SER ALA SER TYR FHE LEU ALA ALA ALA ALA IL E  LYS GLY GLY THR VAL 
G G C G A T G C A T C T T C G G C T T C T T A C T T T C T G G C A G C A G C A G C A A T C A A A G G - C G G C A C T O T A  
[2 4 1 ] 7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0
LYS VAL THR GLY IL E  GLY ARG ASN SER MET GLN GLY ASP IL E  ARG PHE ALA ASP VAL LEU  
a a a g t g a c c g g t a t t g g a c g t a a c a g t a t g c a g g g t g a t a t t c g c t t t g c t g a t g t g c t g  
[2 6 1 ] 7 9 0  8 0 0  8 1 0  8 2 0  8 3 0  *  8 4 0
GLU LYS MET GLY ALA THR IL E  CYS TRP GLY ASP ASP TYR I L ^  SER CYS THR ARG GLY GLU 
G A A A A A A T G G G C G C G A C C A T T T G C T G G G G C G A 7 G A T T A T A T T T C C T G C A C G C G T  t ^ G T G A A 
[28 1 ] 8 5 0  8 6 0  8 7 0  8 8 0  8 9 0  9 0 0
LEU ASN ALA IL E  ASP MET ASP MET ASN H IS  IL E  PRO ASF ALA ALA MET THR IL E  ALA THR 
C T G A A C G C T A T T G A T A T G G A T A T G A A C C A T A T T C C T G A T G C G G C G A T G A C C A T T G C C A C G  
[30 1 ] 9 1 0  9 2 0  9 3 0  . 9 4 0  9 5 0  9 6 0
ALA ALA LEU PHE ALA LYS GLY THR THR ARG LEU ARG ASN IL E  TYR ASN TRP ARG VAL LYS 
G C G G C G T T A T T T G C A A A A G G C A C C A C C A G G C T G C G C A A T A T C T A T A A C T G G C G T G T T A A A  
[3 2 1 ] 9 7 0  9 8 0  9 9 0  1 0 0 0  1 0 1 0  1 0 2 0
GLU THR ASP ARG - LEU PHE ALA MET ALA THR GLU LEU ARG LYS VAL GLY ALA GLU VAL GLU 
g a g a c c g a t c g c c t g t t t ' g l g a t g g c a a c a g a a c t g c g t a a a g t c g g c g c g g a a g t g g a a
[3 4 1 ] 1 0 3 0  1 04 0  1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0
GLU GLY H IS  ASP TYR 
G A G G G G C A C G A  I T A C 
[3 6 1 ] 1 0 9 0
IL E  ARG IL E  THR PRO 
A T T C G T  A T C A C T  C C T  
1100 1110
PRO GLU L YS L EU ASN 
C C G G A A A A A C T G A A C  
1120
PHE AL A GLU I L E AL A
T T T G C C G A G A T C G C G  
1 1 3 0  • 1 1 4 0
THR TYR ASN ASP H IS  ARG MET ALA MET CYS PHE SER LEU VAL ALA LEU SER ASP THR PRO
A C A T A C A A T G A T C A C C G G A T G G C G A T G T G T T T C T C G C T G G T G G C G T T G T C A G A T A C A C C A  
[3 8 1 ] 1 1 5 0  1 16 0  1 17 0  1 18 0  1 1 9 0  1 2 0 0
VAL THR IK E  LEU ASP PRO LYS CYS THR ALA LYS Tfjfc PHE PRO ASP TYR PHE GLU GLN LEU
G T G A C G A T T C T T G A T C C C A A A T  G C A L G G C C A A A A C A T T  I C C G G A T T  A T T T C G A G C A G C T G  
[40 1 ] 1 2 1 0  1 22 0  123 0  1 2 4 0  1 2 5 0  126J.
ALA ARG IL E  SER GLN ALA ALA * » »
G C G C G G A T T A G C C A G G C A G C C T G A  
[42 1 ] 1 2 7 0  1280
CHAPTER 5 
CHEMICAL MODIFICATION OF E. COLI
EPSP SYNTHASE BY BROMOPYRUVATE.
.5.1 Introduction.
As described in section 4.7, the complete amino acid sequence of 
IS. coli EPSP synthase was available from DNA sequencing studies 
(Duncan et al, 1984b). If it were possible to identify the active 
site residues in this amino acid sequence, then the door would be 
opened for site-directed mutagenesis experiments (Winter et al, 1982) 
on EPSP synthase.
Chemical modification is a commonly used method for identifying 
active site residues. By modifying an enzyme with group specific 
reagents and examining the effect that modification has on enzyme 
activity, it is often possible to identify groups that have a role in 
catalysis or binding (Means & Feeney, 1971). However, even if loss 
of enzyme activity is associated with modification of a specific 
residue, this does not guarantee that this residue is located at or 
near the active site. The loss of activity could be due to steric 
hindrance of the active site or to a conformational change brought 
about by the covalent attachment of the modifying group.
Therefore although chemical modification can suggest that a 
particular residue is an active site residue, confirmation of this 
requires further information, for example, substrate protection 
experiments, and preferably knowledge of the three-dimensional 
structure of the enzyme.
Chemical modification of 12. coli EPSP synthase was regarded as 
a potentially useful method for identifying active site residues.
If modification of EPSP synthase by a particular group specific 
reagent resulted in loss of enzyme activity, it might be possible to 
.correlate/
correlate loss of activity with modification of one specific amino 
acid residue. The stoichiometry of inactivation could be determined 
using radioactivelj labelled reagent, if more than one residue was 
modified, the residue(s) necessary for activity might be specifically 
labelled by modifying the enzyme first using unlabelled reagent in 
the presence of protecting ligands, and then treating the enzyme with 
labelled reagent in the absence of ligands. The location of 
specifically labelled residues on the amino acid sequence could be 
subsequently ascertained by standard protein chemical techniques.
This chapter describes preliminary chemical modification 
experiments that were carried out on 12. coli EPSP synthase.
5.2 Chemical modification of EPSP synthase.
5.2.1 An active site thiol?
Some evidence was available that pointed to the importance of a 
thiol group in EPSP synthase activity.
(i) 12. coli EPSP synthase appears to be sensitive to oxidation,
the presence of a reducing agent, for example, DTT, was found 
to be necessary for retention of enzyme activity during 
purification. The N_. crassa EPSP synthase is also sensitive 
to oxidation (Boocock, 1983).
(ii) N_. crassa EPSP synthase can be inactivated by treatment with 
N-ethylmaleimide (M.R. Boocock, unpublished results), this 
reagent modifies cysteine residues.
(iii) UDPGlcNAc enolpyruvyl transferase can be inactivated by the 
antibiotic fosfomycin, this compound has been shown to covalently 
modify a cysteine residue (Kahan et al, 1974). The similarity 
of/
of some of the properties of UDPGlcNAc enolpyruvyl transferase 
to those of EPSP synthase was described in section 1.8.1.
5.2.2 Bromopyruvate.
A number of PEP and pyruvate utilising enzymes have been reported 
to be inactivated by the alkylating agent, 3-bromopyruvate (BrPyr).
The PEP utilising enzymes include pyruvate kinase (Yun & Suelter,1979); 
PEP carboxylase (Kameshita et al, 1979); PEP carboxykinase (Silverstein 
et al, 1980); DAHP synthase (Staub & Denes, 1969) and UDPGlcNAc 
enolpyruvyl transferase (Anwar & Vlaovic, 1980). BrPyr has been 
shown to modify cysteine residues in pyruvate kinase, PEP carboxykinase 
and PEP carboxylase.
In the cases of PEP carboxylase, DAHP synthase and pyruvate 
kinase, BrPyr appears to be acting as an analogue of PEP. This means 
that:
(i) The enzyme can presumably bind BrPyr before irreversible 
modification occurs, i.e.
Enzyme + BrPyr ^  ;■ ...> Enzyme • BrPyr Enzyme - Pyr + Br
Therefore bromopyruvate inactivation shows saturation 
kinetics (Meloche, 1967).
(ii) Since BrPyr binds to the active site of the enzyme, substrates 
afford protection against inactivation.
Because of its successful application to other enzymes, bromo­
pyruvate has been investigated as a possible active-site-directed 
reagent for jS. coli EPSP synthase.
5.3 Bromopyruvate inactivation of EPSP synthase.
E. coli/
J±* c°li EPSP synthase is inhibited by BrPyr and the degree
of inhibition increases with time (figure 5.1). BrPyr inhibition is
not reversible by dialysis. Therefore modification of EPSP synthase
by BrPyr does result in inactivation. However, BrPyr does not
completely abolish EPSP synthase activity, some residual activity
remains (approximately 20-30% of the initial activity).
The rate of inactivation of EPSP synthase by BrPyr appears to
be pseudo-first order for the first 50% of inactivation. It is
evident from figure 5.1 that the rate of inactivation depends on
the concentration of BrPyr. In order to determine whether or not
inactivation showed saturation kinetics, the half-time (ti) of
2
inactivation was determined for a range of bromopyruvate concentrations
and the pseudo-first order rate constant for inactivation, k =app
ln2/t_i, was calculated. Figure 5.2 shows a plot of ^app vs [BrPyr], 
BrPyr inactivation does not appear to show saturation kinetics over 
the concentration range examined (25 to 500 |uM), the rate of 
inactivation appears to be proportional to [BrPyr],
5.4 Substrate protection against bromopyruvate inactivation.
The effect of the presence of substrates and glyphosate on the 
inactivation of EPSP synthase by BrPyr was examined (figure 5.3).
In this experiment carried out with 1 mM BrPyr, it is evident that 
significant protection was afforded only by the presence of shik 3-P 
and glyphosate. When tested singly the substrates had a negligible 
protective effect.
At a lower concentration of BrPyr (0*1 mM) the combination of 
shik 3-P and glyphosate again gave the best protection (figure 5.4).
i
However, both EPSP and glyphosate alone afforded some protection.
EPSP /
. EPSP decreased the rate of inactivation whereas glyphosate appeared 
to decrease the extent of inactivation, as did PEP and shik 3-P to 
some extent.
5.5 Bromopyruvate: an active-site-directed reagent for EPSP synthase?
The somewhat preliminary results presented in sections 5.3 and
5.4 indicated that BrPyr did not appear to be a simple active-site- 
directed reagent for .E. coli EPSP synthase. This statement is based 
largely on the absence of saturation kinetics for the inactivation. 
BrPyr does not appear to bind to EPSP synthase before modification 
occurs.
The observed substrate protection against inactivation implies 
that BrPyr inactivates EPSP synthase by modifying a residue close to 
the active site. However, the stoichiometry of inactivation by BrPyr 
has not been determined. It is possible that the observed substrate 
protection is due to stabilisation of the active conformation of the 
enzyme against modification by BrPyr at many sites.
It is also significant that EPSP synthase activity is not totally 
abolished by treatment with BrPyr. If this reagent does modify a 
cysteine close to the active site of the enzyme, it is unlikely to 
be a cysteine that is involved in formation of a putative Enzyme-PEP 
covalent intermediate. However, it is not yet known whether this 
residual activity is due to incomplete modification or to some 
retention of activity by completely modified enzyme. This question 
might perhaps be resolved by a comparison of the kinetic properties 
(i.e. Michaelis constants) of the native and modified enzymes but 
this has not been attempted.
5.6/
5.6 Inactivation of K. pneumoniae EPSP synthase by bromopyruvate.
BrPyr inactivation of IC. pneumoniae EPSP synthase has been 
reported, including substrate protection studies (Anton et al, 1983; 
Steinrucken & Amrhein, 1984b). The kinetics of inactivation were not 
reported.
Anton eit al (1983) observed substantial protection against 
inactivation by the combination of PEP and 4, 5-dideoxyshikimate 
3-phosphate. This is analogous to the protection of &. coli EPSP 
synthase by shik 3-P and glyphosate. No significant protection by 
PEP or 4, 5-dideoxyshikimate 3-phosphate alone was reported.
However, Steinrucken & Amrhein (1984b) reported that good 
protection against inactivation was given by glyphosate alone. This 
result was part of. the evidence presented (Steinrucken & Amrhein, 
1984a, b) in favour of glyphosate binding to the free enzyme instead 
of binding only to an enzyme*shik 3-P complex as proposed by Boocock 
& Coggins (1983) for the N_. crassa EPSP synthase.
The different patterns of substrate protection observed for the 
12. coli (figure 5.3 and 5.4) and IC. pneumoniae (Steinrucken & Amrhein, 
1984b) EPSP synthases may be due to differences in the conditions 
used for these studies. Steinrucken & Amrhein (1984b) conducted 
inactivation studies in 20 mM Hepes-NaOH pH6*8 whereas this study 
used 50 mM bis Tris-HCl pH6 *8 , 50 mM KC1 (figure 5.4). The substrate 
protection pattern of 12. coli EPSP synthase has been examined in 20 mM 
Hepes-NaOH pH6*8 and is shown in figure 5.5. The pattern observed is 
similar to that reported by Steinrucken & Amrhein (1984b) where 
glyphosate affords good protection, and PEP and EPSP protect to some 
extent.
Anton/
Anton et_ al (1983) carried out inactivation studies in 100 mM 
Tris-HCl pH7*6 and the substrate protection reported was analogous 
to that shown in figure 5.3. It is unlikely that the 12. coli EPSP 
synthase differs significantly from the K . pneumoniae enzyme.
It is unclear why the substrate protection patterns obtained 
for 12. coli EPSP synthase should be somewhat different in bisTris 
and Hepes buffers. 12. coli EPSP synthase activity in 20 mM Hepes- 
NaOH pH6*8 was 65% of the activity in 50 mM bisTris-HCl pH6 *8 , 50 mM 
KC1. Steinrucken & Amrhein (1984a) reported that the activity of 
IC. pneumoniae EPSP synthase was affected by the anion concentration.
5.7 Discussion.
It would be rash to draw conclusions about the order of substrate 
binding to 12. coli EPSP synthase from the preliminary substrate 
protection studies presented in sections 5.4 and 5.6, steady-state 
kinetic studies would be a more reliable way of approaching this 
problem. The question of whether or not glyphosate can bind to the 
free enzyme would perhaps be best examined by a method that involved 
direct measurement of glyphosate binding, for example equilibrium 
dialysis experiments. It is interesting to note however that a 
glyphosate insensitive EPSP synthase, isolated from a glyphosate 
resistant strain of jK. pneumoniae, is not protected by glyphosate 
against BrPyr inactivation (Sost et al, 1984).
As discussed in section 5.5, the stoichiometry of BrPyr 
inactivation must be examined before it can be decided if BrPyr will 
pinpoint a residue at or near the active site of E. coli EPSP ' 
synthase. It may be necessary to turn to other reagents so that 
chemical modification of residues other than cysteine residues can 
be/
.be examined. Steinrucken & Amrhein (1984b) reported that 
K. pneumoniae EPSP synthase was inactivated by phenylglyoxal, a 
reagent that modifies arginine residues. Substrate protection 
against phenylglyoxal inactivation was also reported.
FIGURE 5.1
Bromopyruvate inactivation of EPSP synthase: time dependence.
A sample of EPSP synthase was desalted into 50 mM bisTris-HCl pH6 *8 , 50 mM 
KC1 and treated with BrPyr as described in section 2.8.4. EPSP synthase 
activity was determined at intervals. Each incubation contained 
64 m units EPSP synthase (assayed in the forwards direction).
(□), 0 mM BrPyr; (o), 0*025 mM BrPyr; (•), 0*1 mM BrPyr;
(A ), 0•25 mM BrPyr; (A ), 0•4 mM BrPyr.
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FIGURE 5.2
«- . ....
Bromopyruvate inactivation of EPSP synthase: kinetics of inactivation.
A sample of EPSP synthase was desalted into 50 mM bisTris-HCl pH6 *8 ,
50 mM KC1 and treated with BrPyr as described in section 2.8.4. Each 
incubation contained 64 m units IS. coli EPSP synthase (assayed in the 
forwards direction). The pseudo-first order rate constant (^app) at 
various concentrations of BrPyr was calculated and is plotted against 
[BrPyr].
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FIGURE 5.3
.Bromopyruvate inactivation of EPSP synthase: . protection by ligands I.
A sample of EPSP synthase was desalted into 50 mM potassium citrate 
pH6*8 and treated with BrPyr (1 mM) as described in section 2.8.4 in 
the presence and absence of various ligands. Each incubation contained 
40 m units EPSP synthase activity (assayed in the forwards direction).
(•), no added ligands; (■), 0*2 mM shik 3-P and 0*2 mM glyphosate; 
(A ), 0*2 mM shik 3-P; (A), 0-2 mM PEP; (o), 0-2 mM EPSP.
protecting ligand ti (min) 
2
none 9
shik 3-P + glyphosate 326
PEP 10
shik 3-P 12
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FIGURE 5.4
Bromopyruvate inactivation of EPSP synthase: protection by ligands II.
A sample of EPSP synthase was desalted into 50 mM bisTris-HCl pH6 *8 ,
50 mM KC1 and treated with BrPyr (0*1 mM) as described in section 2.8.4. 
in the presence and absence of various ligands. Each incubation contained 
16 m units EPSP synthase (assayed in the forwards direction).
(•), no added ligands; (■), 0*2 mM shik 3-P and 0*2 mM glyphosate;
(A), 0*2 mM shik 3-P; (A), 0-2 mM PEP; (o), 0*2 mM EPSP; (□), 0-2 mM
glyphosate.
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FIGURE 5.5
Bromopyruvate inactivation of EPSP synthase: protection by ligands III.
A sample of EPSP synthase was desalted into 20 mM Hepes-NaOH pH6*8 
and treated with BrPyr (0*2 mM) as described in section 2.8.4 in the 
presence and absence of various ligands. Each incubation contained 104 
m units EPSP synthase (assayed in the forwards direction). (•), no 
added ligands; (A), 0*2 mM shik 3-P; ( A) ,  0*2 mM PEP; (o), 0*2 mM
EPSP; (□), 0*2 mM glyphosate.
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CHAPTER 6
THE PURIFICATION AND PROPERTIES OF PHOSPHOSERINE 
AMINOTRANSFERASE FROM E. COLI AB2829/pKD501
6.1 Introduction
6.1.1 A second protein is overexpressed by E. coli AB2829/pKD501.
The overproducing strain, E,. coli AB2829/pKD501, appears to over­
express another protein in addition to EPSP synthase. A comparison of 
SDS PAGE of crude extract fractions of IS. coli AB2829/pKD501 (figure 4.5, 
track A) and of E. coli K12 (figure 3.5, track A) indicated that IS. coli 
AB2829/pKD501 produces large amounts of a polypeptide of M^ 40,000 
which does not appear to be produced to such an extent by IS. coli K12.
When a systematic attempt was made by Mr. K, Duncan to reduce the 
.size of the DNA insert in pKD501 (a 4*6 kb Pstl fragment) to the 
minimum that would still permit overexpression of EPSP synthase, it 
was found that the level of EPSP synthase overproduction fell as soon 
as any of the upstream DNA sequence within 1*2 kb of the initiation 
codon of the aroA gene was deleted (Duncan, 1984). When this region 
was sequenced it was found to contain an open reading frame large 
enough to code for a 362 amino acid polypeptide with a calculated M^ 
of 39834 (Duncan, 1984).
The gene corresponding to this open reading frame has been identified 
as the serC gene. The serC gene codes for the enzyme, 3-phosphoserine:
2-oxoglutarate aminotransferase (PSAT), an enzyme of serine 
biosynthesis. The serC and aroA genes appear to be co-ordinately 
transcribed from a single promoter upstream of the serC gene. In 
IS. coli strains harbouring pKD501, which carries both the serC and 
aroA genes, both PSAT and EPSP synthase are overproduced (Duncan, 1984).
As part of a collaborative effort with Mr. K. Duncan to confirm 
the identity of the M^ 40,000 polypeptide as PSAT, it was decided to 
attempt/
attempt the purification and characterisation of PSAT from IS. coli 
AB2829/pKD501.
It is evident from figure 4.5 that the M^ 40,000 polypeptide believed 
to be PSAT was present in fairly large quantities in the phenyl- 
Sepharose pool of EPSP synthase activity purified from IS. coli 
AB2829/pKD501. It therefore seemed likely that the purification 
scheme initially developed for EPSP synthase could be modified and 
used to purify the serC gene product. The purification scheme which was 
devised for IS. coli PSAT is described in this chapter. Some properties 
of the purified enzyme are also described including protein chemical 
studies that were undertaken to demonstrate that the purified protein 
was the product of the serC gene.
6.1.2 Serine biosynthesis in E. coli.
Serine is synthesised in three steps from the glycolytic inter­
mediate, 3-phosphoglycerate (figure 6.1). Pizer (1963) demonstrated 
that this pathway is a major route to serine in IS. coli. Mutants 
lacking one of these enzyme activities require serine for growth.
The enzymes of serine biosynthesis are synthesised, constitutively, 
carbon flow through this pathway appears to be controlled largely by 
feedback inhibition of the first enzyme, 3-phosphoglycerate dehydro­
genase, by serine (McKitrick & Pizer, 1980). PSAT and 3-phosphoserine 
phosphatase do not appear to be controlled (Pizer, 1963).
6.1.3 Phosphoserine aminotransferase and pyridoxine biosynthesis.
The role of PSAT in serine biosynthesis is well-established.
However, 15. coli serC mutants require both serine and pyridoxine for 
growth (Dempsey, 1969a; Shimizu & Dempsey, 1978), serA and serB 
mutants/
mutants require serine only. It was suggested that PSAT was involved 
in pyridoxine biosynthesis as serC mutants do not synthesise pyridoxine 
(Dempsey, 1969b).
Shimizu & Dempsey (1978) demonstrated that 15. coli K12 serC 
mutants revert readily to pyridoxine independence, this reversion is 
associated with elevated levels of serine: 2-oxoglutarate aminotrans­
ferase activity. The mutation resulting in pyridoxine independence 
was closely linked to aroA. The growth requirement of serC mutants 
for pyridoxine could be replaced by 3-hydroxypyruvate. Shimizu &
Dempsey (1978) suggested that the role of PSAT in pyridoxine biosyn­
thesis was the transamination of small amounts of serine to give
3-hydroxypyruvate. The importance of 3-hydroxypyruvate in pyridoxine 
biosynthesis is not understood.
6.1.4 Phosphoserine aminotransferases.
15. coli B PSAT has been purified to near homogeneity and some 
properties of the purified enzyme reported (Itoh & Dempsey, 1970).
The native M was estimated to be 80,500 by sucrose density gradient 
centrifugation but the subunit was not reported. The U.V. absorption 
spectrum of the isolated enzyme indicated that it contained pyridoxal 
phosphate.
PSAT has been purified to homogeneity from sheep brain. The 
native of the mammalian enzyme was 96,000 determined by ultra- • 
centrifugation; again the enzyme was isolated with pyridoxal phosphate 
bound (Hirsch & Greenberg, 1967).
6.2 PSAT levels in E. coli K12 and E. coli AB2829/pKD501.
PSAT activity was assayed in 100,000 g supernatants of 15. coli K12
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and IS. coli AB2829/pKD501 by coupling the production of 2-oxoglutarate 
to the glutamate dehydrogenase reaction, the keto acid was 3-hydro­
xypyruvate (OHPyr) in the routine assay (section 2.5.2). PSAT 
activity was difficult to determine accurately owing to two interfering 
activities:
(i) a OHPyr-independent NADH oxidase activity - this was corrected 
for by running an assay without OHPyr,
(ii) a OHPyr-dependent NADH oxidation that was corrected for by 
running an assay without glutamate dehydrogenase.
The specific activity of PSAT in IS. coli K12 extracts was 
approximately 0*011 units/mg and in E. coli AB2829/pKD501 extracts 
was 1*06 units/mg. Thus IS. coli AB2829/pKD501 contains approximately 
96-fold elevated levels of PSAT activity. This is very similar to the 
level of EPSP synthase overproduction by IS. coli AB2829/pKD501 
(section 4.2).
6.3 Purification of PSAT from E. coli AB2829/pKD501.
The early parts of the purification procedure are a modification 
of the method used to purify EPSP synthase from the overproducing 
strain. PSAT activity was monitored throughout the purification with 
OHPyr as substrate in the assay described in section 2.5.2.
Details of the purification are summarised in Table 6.1.
(a) Crude extract preparation and (NH/^pSO^ fractionation.
These steps were carried out as described previously (section 3.2
(a) and (b)). The 50-70% saturated (NH^^SO^ fraction contained a 
large proportion of the total PSAT activity (Table 6.1), it also 
contained the OHPyr-dependent NADH oxidase, however this was removed
by the next step in the purification procedure.
(b) DEAE-Sephacel chromatography.
Conditions were as described in section 4.3(b). PSAT was 
located in fractions following those containing EPSP synthase activity 
but the separation was incomplete and the accompanying protein peak 
overlapped the two peaks of activity (figure 6.2). The fractions 
corresponding to the protein peak were pooled and subjected to • 
chromatography on phenyl-Sepharose.
(c) Phenyl-Sepharose chromatography.
The procedure was as described in section 3.2(d) except that a 
400 ml gradient was used. The elution profile is shown in figure 6.3. 
PSAT activity was eluted from the phenyl-Sepharose column in two peaks, 
both of which were clearly resolved from the peak of EPSP synthase 
activity. The occurrence of two peaks of PSAT activity may have been 
due to overloading of the column. The two peaks of PSAT activity were 
pooled separately (figure 6.3) and the purity of the pools was examined 
by SDS PAGE. Only the Mr 40,000 polypeptide.was present in both pools. 
Pool I also contained two other polypeptides (figure 6.4, track D), 
while pool II contained at least four polypeptides in addition to the 
one of 40,000 (not shown). The polypeptide of 40,000 was the major 
species in both pools. ■ * '
PSAT present in pool I was subsequently purified to homogeneity 
by ion-exchange chromatography on a mono-Q column.
(d) Ion-exchange chromatography on mono-Q.
Pool I of PSAT activity from chromatography on phenyl-Sepharose 
was concentrated by vacuum dialysis until the final volume was 
approximately 2 ml. It was then dialysed against 1 1 25 mM Tris-HCl 
pH7-5/
pH7*5, 0*2 mM DTT overnight. Because of the limited capacity of the 
mono-Q column, ion-exchange chromatography was carried out on batches 
of this concentrated, dialysed material. The mono-Q column was 
equilibrated with 25 mM Tris-HCl pH7*5, 0*2 mM DTT, the flow rate 
throughout was 1*0 ml/min and the column eluate was monitored at 
280 nm. The sample was loaded on to the column (5*3 mg protein in 
200 jxl), and the column was washed with 25 mM Tris-HCl pH7*5, 0*2 mM 
DTT for 4 min. Then a linear gradient of 0 to 0*5 M KC1 in 25 mM 
Tris-HCl pH7*5, 0*2 mM DTT was applied over 50 min , 0*5 ml fractions 
were collected during gradient application.
This procedure resulted in the resolution of two protein peaks 
(figure 6.5). PSAT activity was associated with the second major 
peak. Portions of fractions containing PSAT activity were subjected 
to SDS PAGE, those fractions containing only the polypeptide of M^
40,000 were combined. Homogeneous PSAT was dialysed against 50 mM 
Tris-HCl pH7*5, 0*2 mM DTT, 50% (v/v) glycerol and stored at -20°C.
The specific activity of the purified enzyme was 3*11 units/mg 
(Table 6.1). The yield of homogeneous enzyme was low but only one 
quarter of phenyl-Sepharose pool I was subjected to ion-exchange 
chromatography on mono-Q. There must be some doubt about the measurement 
of PSAT activity in the crude extract and 50-70% (NH^^SO^ fractions 
because of the activities that interfere with the assay of PSAT activity 
described in section 6.2. Therefore, the purification factor given,
6 *9-fold, must be regarded as tentative. However, PSAT comprises a 
very substantial fraction of the extractable protein from E. coli 
AB2829/pKD501.
6-4/
6.4 Purity and molecular weight.
Figure 6.4 shows an SDS gel that monitors the purification of 
PSAT from IS. coli AB2829/pKD501. After non-denaturing PAGE, purified 
PSAT showed only one protein band, which corresponded with an activity 
staining band (figure 6 .6).
The subunit of PSAT was determined to be 39,000 by SDS PAGE 
(figure 6.7). This agrees well with the calculated of 39,834 derived 
from the DNA sequence (Duncan, 1984).
It is probable that _E. coli PSAT is a dimeric enzyme. The native 
M of purified PSAT was estimated to be 68,000 by HPLC gel filtration 
on a TSK G3000SW column (figure 6 .8). This estimate is somewhat
lower than expected for a dimer of 40,000 subunits. It was
reported that highly purified PSAT of IS. coli B had a native 
of 80,500 (Itoh & Dempsey, 1970).
6.5 Amino acid composition and N-terminal sequence of PSAT.
(a) Amino acid composition.
The amino acid composition of E. coli PSAT was determined as 
described in section 2.8.1. The composition is shown in Table 6.2, 
it is based on 30 Leu residues per PSAT subunit so that the amino 
acid composition determined at the protein level can be easily
compared with that derived from the DNA sequence of the serC gene
(Duncan, 1984). It is evident that the agreement between the 
compositions shown in Table 6.2 is very good.
(b) The N-terminal amino acid sequence.
The N-terminal amino acid sequence of E. coli PSAT was
determined by automatic protein sequencing of the intact protein as 
described/
TABLE 6.2
The amino acid composition of EL coli PSAT compared with the amino 
acid composition deduced for PSAT from the EL coli serC gene sequence. •
Amino acid
Relative amino 
. acid composition 
based on 
Leu = 30 residues
Theoretical amino 
acid composition 
predicted from 
the DNA sequence
Asp 39*6 45
Thr1 12*5 12
Ser^ 20-2 20
Glu 33-3 30
Pro 15-7 15
Gly 31.4 28
Ala 43-2 41
Cys2 4*7 4
Val3 28-1 28
Met4 10*4 11
H e 3 18*8 19
Leu 30 30
Tyr 13.1 13
Phe 18-4 18
His 6*2 6
Lys 19-8 20
Arg 16*6 17
Trp ND 5
* Experimental values were extrapolated to zero time.
2
Determined as cysteic acid.
3
Average of 96 h experimental values.
i\.
Determined as methionine sulphone. .
Samples were analysed in duplicate after hydrolysis of performic acid 
oxidised-protein with 6 M HC1 at 105°C for 24, 48, 72 and 96 h. The 8
described in section 2.8.2. The N-terrainal sequence is shown in 
figure 6.9 , this sequence can be compared with that deduced from the 
DNA sequence of the E. coli serC gene (figure 6.10; Duncan, 1984).
The N-terminal amino acid of PSAT is Ala, not Met, presumably the 
initiating Met is removed after synthesis of PSAT. It should be noted 
that the amino acid composition derived from the protein contains one 
less Met-than the composition deduced from the DNA sequence.
Gaps in the sequence shown in figure 6.9 indicate residues where the 
PTH-amino acids could not be identified. Otherwise the N-terminal 
amino acid sequence agrees well with that derived from the DNA sequence. 
The exception is at residue 18. The protein sequence indicates Phe 
(figure 6.9) whereas the DNA sequence predicts Leu (figure 6.10).
As the chromatographic conditions used to separate the PTH-amino acids 
(Carter et al, 1983) result in PTH-Phe and PTH-Leu being eluted very 
close together, it is possible that PTH-Leu may have been eluted at the 
position normally occupied by PTH-Phe and the chromatogram misinter­
preted. The good agreement between the amounts of Leu and Phe in 
the experimentally derived and predicted compositions (Table 6.2) 
tends to support the view that residue 18 is Leu and not Phe.
6.6 Properties of E. coli PSAT.
6.6.1 Substrate specificity.
E. coli PSAT was assayed throughout the purification procedure 
using OHPyr as substrate. The physiological substrate for this 
enzyme was reported to be 3-phosphohydroxypyruvate (P-OHPyr; Pizer,
1963). The purified PSAT does transaminate this keto acid. Relative 
rates/
TABLE 6.3 
Relative rates of PSAT activity.
keto acid amino acid
Relative PSAT 
activity 
(%)
3-phosphohydroxypyruvate Glu 172
pyruvate Glu 151
hydroxyphenylpyruvate Glu 0
phenylpyruvate Glu 1-8
oxaloacetate Glu 96
3-hydroxypyruvate ’ Glu 100
3-hydroxypyruvate Asp 70
2-oxoglutarate Ser 1-1
2-oxoglutarate 3-phosphoserine 0-9
Relative rates of EL coli PSAT activity with different pairs of 
substrates are compared, the rate with the substrate pair 3- 
hydroxypyruvate/Glu was taken as 100%. PSAT activity.was assayed 
as described in section 2.5.2.
rates of PSAT activity with a number of keto acids and amino acids .are 
shown in Table 6.3. Evidently PSAT can transaminate keto acids other
I
than P-OHPyr and OHPyr as pyruvate and o*aloacetate are also substrates. 
Aromatic keto acids are not transaminated. A total description of the 
substrate specificity of E. coli PSAT would require the determination 
of kinetic parameters for each substrate and this has not so far been 
attempted.
6.6.2 Kinetic properties.
E. coli PSAT is inhibited by high concentrations of P-OHPyr. This 
keto acid is therefore a better substrate for PSAT than is evident 
from Table 6.3. Figure 6.11 shows a double reciprocal plot of 
initial velocity against [glutamate] at fixed concentrations of P-OHPyr.
At low [P-OHPyr] the lines appear parallel but the slope is increased 
by increasing P-OHPyr. This kinetic pattern is typical of a ping- 
pong mechanism with competitive inhibition by the second substrate 
(Cleland, 1971). values for P-OHPyr and glutamate were estimated 
from secondary plots to be 4*0 juM and 1*2 mM respectively.
The Michaelis constants determined at fixed [glutamate] (3 mM) 
for P-OHPyr and OHPyr were 2*5 pM and 167 pM respectively. This 
indicates that OHPyr is not as good a substrate as P-OHPyr.
It is evident from Table 6.3 that transamination is reversible 
although the observed rate is only approximately 1% of the rate in the 
forwards direction.
6.6.3 Pyridoxal phosphate and PSAT.
Purified _E. coli PSAT if 'je-lUw colou/£<i. Ita absorption speckru.*A o{ 
{foe purified enfctjwe ( f i y a . i ' C  G.lta) indi'ctfte's t h a t  P5AT is is o laW j tk
p M o d o x d  p ko sp K ak?  ( f^ P ^  R c o o v c ru  o|- P s * y r  nc-fciv/chj
TABLE 6.4
The effect of pyridoxal phosphate on PSAT activity.
Additions
Recovery of 
PSAT activity 
(m units)
none 26
50 jaM pyridoxal phosphate 25
100 |uM glutamate 13
100 pM 3-hydroxypyruvate 24
Aliquots of purified E. coli PSAT (28 m units) were 
dialysed against 50 mM Tris-HCl pH8*2, 0*4 mM DTT with the 
additions specified above. After 24 h, PSAT activity was 
determined using the routine assay method (section 2.5.2).
was good although the buffers used in the purification procedure did 
not contain PLP. Addition of PLP to assay mixtures does not result 
in increased PSAT activity.
Table 6.4 shows that no increase in PSAT activity was observed 
after dialysis of purified enzyme against 50 jaM PLP. Dialysis against 
100 pM glutamate does decrease PSAT activity. This type of inactivation
has also been observed for the highly purified PSAT of EL coli B.
Itoh & Dempsey (1970) suggested that dissociation of pyridoxamine 
phosphate might occur more readily than PLP dissociation. The PSAT 
activity lost by dialysis against glutamate was not recovered by 
subsequent incubation of the inactivated enzyme in 50 |wM PLP, 
restoration of activity using pyridoxamine phosphate was not attempted.
6.6.4 Discussion.
The properties of EL coli PSAT described above can be regarded
as properties expected of an aminotransferase.
(i) PSAT appeared to be isolated with tightly bound PLP;
(ii) the initial velocity kinetic patterns of E. coli PSAT were of 
the non-intersecting type;
(iii) PSAT catalyses the transamination of a number of structurally 
related substrates.
Phosphoserine aminotransferases have also been purified from 
EL coli B (Itoh & Dempsey, 1970) and sheep brain (Hirsch & Greenberg, 
1967). Both of these isolated enzymes contained tightly bound PLP.
The EL coli B PSAT showed non-intersecting initial velocity kinetic 
patterns. This enzyme was assayed in the reverse direction with 
3-phosphoserine and 2-oxoglutarate as substrates, the kinetics 
of the forward reaction were not described (Itoh & Dempsey, 1970).
The mammalian PSAT differs from the E. coli AB2829/pKD501 enzyme in 
that/
that it does not transaminate OHPyr. Inhibition of the sheep brain 
PSAT was observed at high concentrations of P-OHPyr (Hirsch & Greenberg, 
1967).
6.7 Comparison of E. coli PSAT with other aminotransferases.
As the amino acid sequence and some of the properties of EL coli 
PSAT have now been established it is interesting to compare PSAT with 
some of the other aminotransferase (AT) activities which have been 
characterised.
EL coli PSAT appears to be a dimeric protein of subunit Mr 40,000.
The EL coli aspartate AT and aromatic amino acid AT have been shown to
Subancf
be dimeric enzymes °f/M 43,000 and 46,000 respectively (Powell & 
Morrison, 1978). S>. typhimurium imidazolylacetolphosphate:glutamate AT
may also be a dimer of subunits of M^ approximately 30,000 (Martin et al, 
1967) although this enzyme has been less well characterised. However, 
the EL coli branched chain amino acid AT appeared to be a hexameric 
protein of subunit M^ 31,000 (Lee-Peng et al, 1979).
Some sequence data have been reported for all of these amino­
transferases. Limited N-terminal amino acid sequences of the 
imidazolylacetolphosphate:glutamate AT (13 amino acids) and the 
branched chain amino acid AT (81 amino acids) have been deduced from 
DNA sequencing studies of the _S. typhimurium hisC gene (Riggs & Artz, 
1984) and the EL coli ilvE gene (Lawther et al, 1978) respectively.
The complete DNA sequence of the EL coli tyrB gene (which codes for 
the aromatic amino acid AT) has been determined (M. Edwards, unpublished 
results)., The complete amino acid sequences of a number of aspartate 
aminotransferases have been determined by protein sequencing. These 
include/
include the E. coli enzyme (Kondo et al, 1984), pig heart mitochondrial 
(Kagamiyama et al, 1980) and cytosolic (Ovchinnikov et al, 1973) 
aspartate AT and the chicken cytosolic enzyme (Shlyapnikov et al, 1979). 
The sequence of the E. coli aspartate AT is 40% homologous with the pig 
heart isoenzymes.
The EL coli tyrB gene product shows homology with these aspartate 
aminotransferases. This is illustrated by the dot-plot (Maizel & Lenk, 
1981) shown in figure 6.12 where a line of homology between the EL coli 
aromatic AT and the chicken cytosolic aspartate AT is evident. However, 
no homology between the tyrB gene product and EL coli PSAT was detected 
in the same type of test (figure 6.13; K. Duncan, unpublished results). 
Similarly, homology of the EL coli PSAT sequence with the limited 
N-terminal sequences of the imidazolylacetolphosphate:glutamate AT and 
the branched chain amino acid AT is not evident.
In view of the different substrate specificities of these amino­
transferases, it is perhaps not surprising that homology between the 
amino acid sequence of EL coli PSAT and the sequences of the other 
aminotransferases cannot be readily detected. The homoiogy observed 
between the aromatic amino acid AT and aspartate AT (figure 6.12) is 
explicable as aspartate AT can catalyse transaminations involving 
aromatic amino acid substrates and vice versa (Powell & Morrison, 1978).
6.8 Further discussion.
Phosphoserine aminotransferase has been purified to homogeneity 
from E. coli AB2829/pKD501, a strain which overproduces both PSAT 
and EPSP synthase. PSAT required approximately 7-fold purification 
from EL coli AB2829/pKD501, PSAT of EL coli B required 519-fold 
.purification/
purification to near homogeneity (Itoh & Dempsey ,
The purification factor for EPSP synthase from the overproducing 
strain was approximately 50-fold (Table 4.1), therefore it seems that 
E. coli AB2829/pKD501 cells contain more PSAT than EPSP synthase by 
mass. The serC-aroA operon appears to be transcribed from a single 
promoter, however, there is a transcriptional terminator between the 
serC and aroA genes which will reduce the number of complete serC-aroA 
messengers (Duncan, 1984). This provides a rationale for the different 
amounts of the two gene products although some form of translational 
control cannot be ruled out.
The protein chemical properties of purified PSAT confirm that it 
is the product of the gene upstream of aroA that had been identified as 
the serC gene. The amino acid compositon and N-terminal amino acid 
sequence presented in section 6.5 agree well with the protein sequence 
deduced from the DNA sequence of the serC gene (Duncan, 1984). The 
kinetic properties of E, coli PSAT described in section 6.6 are 
consistent with the proposed physiological role of this enzyme in 
serine biosynthesis, the transamination of P-OHPyr to give 3-phospho- 
serine.
These studies on the isolated enzyme do not explain the pyridoxine 
requirement for growth of E. coli serC mutants (Dempsey, l'969a).
E.* coli PSAT does catalyse the production of OHPyr from serine albeit 
at a somewhat low rate compared to the reverse reaction. Whether or 
not OHPyr production is one of phosphoserine aminotransferase’s roles 
in vivo remains an open question.
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Figure 6.1 Serine biosynthesis in IS. coli.
FIGURE 6.2 . 
DEAE-Sephacel chromatography.
The 50-70% saturated (NH^^SO^ fraction was loaded on to a column of 
DEAE-Sephacel and chromatographed as described in section 4.3(b). 
(o), ^2qq; (•), EPSP synthase activity; (A), PSAT activity;
( □ —  O ), conductivity.
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FIGURE 6.3 
Chromatography on phenyl-Sepharose.
The pool of EPSP synthase and PSAT activities from chromatography on 
DEAE-Sephacel was treated with (NH^^SO^ (164 g/1) and loaded on to a 
column of phenyl-Sepharose equilibrated in buffer. B containing 0*8 M 
(NH^^SO^ as described in section 3.2(d). A gradient (total volume,
400 ml) of 0*8 to 0 M (NH^^SO^ in buffer B was applied. The flow 
rate was 80 ml/h and 8 ml fractions were collected, (o), (•),
EPSP synthase activity; (A), PSAT activity; (□ —  □), conductivity. 
The fractions included in pool I and pool II of PSAT activity are 
indicated.
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EIGURE 6.4
The purification of PSAT from IS. coli AB2829/pKD501.
This 12.% polyacrylamide SDS gel monitors the purification of PSAT 
from IS. coli AB2829/pKD501. Track A, crude extract (141 |ig protein); 
track B, 50-70% (NH^^SO^ fraction (81 jig); track C, DEAE-Sephacel 
pool (46 fig); track D, phenyl-Sepharose pool I (24 ftg); track E, 
mono-Q pool (4 fig).
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FIGURE 6.5 
Ion-exchange chromatography on mono-Q.
Ion-exchange chromatography was carried out as described in section 6.3 
(d). A portion of concentrated PSAT pool I from phenyl-Sepharose 
chromatography (5*3 mg protein) was loaded on to the mono-Q column.
A gradient of 0 to 0*5 M KC1 in 25 mM Tris-HCl pH7*5 was applied. The 
column eluate was monitored at 280 nm. The section of gradient shown 
(0*2 M to 0*5 M KC1) is that in which peaks of material absorbing at 
280 nm were eluted.
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FIGURE 6.6
Non-denaturing PAGE of IS. coli PSAT.
Samples of purified PSAT were subjected to non-denaturing PAGE 
(section 2.3.1). Gel A was stained for protein (2*6 jug loaded), 
gel B was stained for PSAT activity (9 m units loaded, section 2.3.3).
A B
EIGURE 6.7
Standard curve of .R^  against log Mr.
SDS PAGE (10% polyacrylamide gel) was carried out as described in 
section 2.3.2. The R^ values of proteins of standard Mr (section 2.8.3) 
were calculated and are plotted against log (•). The R^ value of 
purified PSAT is shown (o).
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FIGURE 6.8
Standard curve of Vg against log M^ .
A TSK G3000SW column was calibrated with the standard proteins (#)
listed in section 2.8.3. The V of E. coli PSAT is shown (o).e —  ----
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figure 6.9
The N-terminal amino acid sequence of Eh coli PSAT.
1 10
Ala - Gin - lie - Phe - Asn - Phe - Ser - Ser - Gly - Pro -
11 20
Ala - Met - Leu - Pro - (-) - Glu - Val - Phe - Lys - Gin -
21 30
Ala - Gin - Gin - (-) - Leu - Arg - Asp - Trp - Asn - Gly -
31 37
Leu - (-) - (-) - (-) - (-) - Met - Glu -
The sequence was determined on a liquid phase sequencer as 
described in section 2.8.2. The initial amount of protein 
sequencing was 25 nmol and the repetitive yield from residues 
1 to 37 was 91*7% (correlation coefficient 0*94).
Continued over.
FIGURE 6.9 (continued)
Sequence PTH-amino nmoles
number acid recovered
1 Ala 22? 5
2 Gin 25-1
3 H e 13-0
4 Phe 23-8
5 Asn 22-4
6 Phe 21-0
7 Ser -
8 Ser -
9 Gly 7*0
10 Pro 16-5
11 Ala 12-6
12 Met 14-2
13 Leu 9-6
14 Pro 9-5
15 - -
16 Glu 7*3
17 Val 12*9
18 Phe 10-3
19 Lys 6-4
20 Gin 5-5
21 Ala 6-0
22 Gin 5*5
23 Gin 5-4
24 -
25 Leu 2-9
26 Arg 2-7
27 Asp 5*3
28 Trp 1-5
29 Asn 2*0
30 Gly 1-1
31 Leu 1*8
32 - • —
33 - -  ■
34 - -
35 - - ■
36 Met -
37 Glu 1*3
FIGURE 6.10
The DNA sequence of the EL coli serC gene.
The complete nucleotide sequence of the EL coli serC gene and the 
corresponding amino acid sequence of EL coli phosphoserine amino­
transferase. Nucleotides are numbered in the 5’ to 3* direction 
beginning with the first residue of the ATG triplet encoding the 
initiating methionine. The bracketed numbers refer to the amino acid 
positions in the sequence.
10 30 50
ATGGCTCAAATCTTCAATTTTAGTTCTGGTCCGGCAA^GCTACCGGCAGAGGTGCTTAAA
 +  + + +  + +
MetAlaGl n l 1ePheAsnPheSerSerG1vProAlaMetLeuProA)aGluVa1LeuLys 
C13 -
70 90 110
CAGGCTCAACAGGAACTGCGCGACTGGAACGGTC7TGGTACGTCGGTGATGGAAGTGAGT
G 1n A 1a G 1n G 1n G 1uLei_Arg AspTrpAsnG1yLeuGIyThrSerVa1 Me tG1uVa1Ser 
[213
130 150 • 170
CACCGTGGCAAAGAGTTCATTCAGGTTGCAGAGGAAGCCGAGAAGGATTTTCGCGATCTT
 + + + +  + +
H isArgG1 yLysG 1 uPhe II eG 1 nVa 1 A 1 aG 1 uG 1 u A 1 aG 1 uLysAspPheArg AspLeu 
[413
190 210 230
CTTAATGTCCCCTCCAACTACAAGGTATTATTCTGCCATGGCGGTGGTCGCGGTCAGTTT
 + + -—  - + -   + ------------------ + +
LeuAsnVa1ProSerAsnTyrLysVa1LeuPheCysHisG1y G 1yG 1yArgGl yGlnPhe
t e n
250 270 290
GCTGCGGTACCGCTGAATATTCTCGGTGATAAAACCACCGCAGATTATGTTGATGCCGG7
 + +  + +  +  +
A 1a A 1aVa1ProLeuAsnI 1eLeuG1yAspLysThrThrA1aAspTyrVa1AspA1aG1y 
[813
310 330 350
TACTGGGCGGCAAGTGCCATTAAAGAAGCGAAAAAATACTGCACGCCTAATGTCTTTGAC
 + + +  +  + +
TyrTrpAlaA1aSerA1 a I 1eLysG1uAIaLysLysTyrC ysThrProAsnVa1PheAsp 
[1013
3/ 0 39 0 4 i 0
GCCAAAGTGACTGTTGATGGTCTGCGCGCGGTTAAGCCAATGCGTGAATGGCAACTCTCT
—  *" -  “  “  ”  -  —  —  -  —  —  —  4 —  —  —  —  —  —  —  —  —  4 —  -  —  —  —  -  — 4. —  —  —  —  —  —  —  —  — 4 — -  —  —  —  —  -  —  —  +
A 1 aLysVa 1 ThrVa 1 AspG 1 yLeuAraA) aVa 1 LysProMe tArgG 1 uTrpG 1 nLeuSer 
[1213
Figure 8*10: Coding sequence of the E. coli serC gene.
430 450 470
GATAATGCTGCTTATATGCATTATTGCCCGAATGAAACCATCGATGGTATCGCCATCGAC
 + - -   + +   +  +  +
AspAsnA1aAlaTyrMe tHisTyrCysProAsnG1uThrI 1eAspG1y11e A 1 a I 1eAsp 
[1413
490 510 530
GAAACGCCAGACTTCGGCGCAGATGTGGTCGTCGCCGC7GACTTCTCTTCAACCATTCTT
•“ “ +  *" —  — — — — 4 — — — — -  -4
G 1 uThrProAspPheG 1 yA 1 aAspVa 1V a 1V a 1A 1aAI aAspPheSerSerThr 11 eLeu. 
[1613
550 570 590
TCCCGTCCGATTGACGTCAGCCGTTATGGTGTAATTTACGCTGGCGCGCAGAAAAATATC
---------------------------+ ----------------------------4   4  4 -    + ----------------+
SerArgProI1eAspVa1SerArqTyrG1yVa111 elyrA1a G 'yAlaGInLysAsnlIe 
[1813
610 630 650
GGCCCGGCTGGCCTGACAATCGTCATCGTTCGTGAAGATTTGCTGGGCAAAGCGAATATC
 + + +  +  + +
G 1 vProA 1 aGl yLeuThrI 1 eVa 1 I 1 eVa 1 AroG 1 uAspLeuLeuG 1 yLysAl aAsnl 1 e 
[20 i 3
670 690 7 iO
GCGTGTCCGTCGATTCTGGATTATTCCATCCTCAACGATAACGGCTCCATGTTTAACACG
  + +   +  +  + +
A1aCysProSer11eLeuAspTyrSer11eLeuAsnAspAsnG1ySerMetPheAsnThr 
[2213
730 750 770
CCGCCGACATTTGCCTGGTATCTATCTGGTCTGGTCTTTAAATGGCTGAAAGCGAACGGC
 + + +  +  + +
ProProThrPheA 1 aTrpTyrLeuSer-G 1 vLeuVa 1 PheLysTrpLeuLysA 1 aAsnG 1 y 
[2413
790 310 830
GGTGTAGC7GAAATGGATAAAATCAATCAGCAAAAAGCAGAACTGCTATATGGGGTGATT
 + + +   + + +
G 1 yVa 1A 1 aG 1 uMet AspLysI 1 eAsnG 1 nG ! nLysA 1 aG 1 uLeuLeuTyr-G 1 yVa 1 I 1 e 
[2613
Figure 6.10 (cont.)
841
901
961
1021
1081
850/ 870 890
GATAACAGCGATTTCTACCGCAATGACGTGGCGAAACGTAACCGTTCGCGGATGAACGTG
- - - - - - - - - 4 —  - - - - - - - - 4 . . - -  - - - - 4 - - - - — —  -  4 -  _ _ _ . _ _ - . _ _ 4 _ - - - - - - - -  4
AspAsnSerAspPheTyrArgAsnAspVa 1A1 aLysAroAsnArgSerArqMetAsnVa 1 
C2813
9 1 0  9 3 0  9 5 0
CCGTTCCAGTTGGCGGACAGTGCGCTTGACAAATTGTTCCTTGAAGAGTCTTTTGCTGCT
--------------------------+ ----------------------  4 —  _  _  _ _  _  _  _  +  —  -  4 —  —  —  —  -  -  —  —  —  4  —  —  —  —  -  -  —  “ -4
ProPheGlnLeuAl aAspSerAl aLeuAspLysLeuPheLeuG \ uG 1 uSer-PheAl aA 1 a 
[3013
970 990 1010
GGCCTTCATGCACTGAAAGGTCACCGTGTGGTCGGCGGAATGCGCGCTTCTATTTATAAC
--------------------  4 ---------------------------------------+ -------------------------------------- + ---------------------------------------+ --------------------------------------- + ---------------------------------------- +
G 1 yLeuHisAI aLeuLysG 1 yHisAroVa ) Va 1G 1 yG 1 yMe t ArqA 1 aSer I ) eTyrAsn 
[3213
1030 1050 1070
GCCATGCCGCTGGAAGGCGTTAAAGCGCTGACAGACTTCATGGTTGAGTTCGAACGCCGT
---------- +---------- 4---------- +---------- +-----------+---------- 4
AI aMetProLeuGl uGl yVa 1 LysAl aLeuThr AspPheMe tVa \ G luPheGl uArqArg 
[3413
CACGGTTAA
..........  1089
HisG 1yEnd 
[3613
FIGURE 6.11 
Double reciprocal plot of IS. coli PSAT.
A double reciprocal plot of initial velocity vs [glutamate] at a 
series of fixed P-OHPyr concentrations: (D), 50 juM; (A), 10 ymM;
( A ) ,  5 juM; (•), 3*3 pM; (o), 2 juM. Inset: replot of intercepts
as a function of [P-OHPyr].
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FIGURE 6.12
A comparison of the amino acid sequences of IS. coli 
aromatic amino acid AT and chicken cytosolic aspartate AT.
A dot-plot produced by a search for sequence homology (Maizel & Lenk, 
1981; Devereux et al, 1984) between the amino acid sequences of 
IS. coli aromatic amino acid AT (M. Edwards, unpublished results) and 
chicken cytosolic aspartate AT (Shlyapnikov et al,1979). A dot 
indicates that a match of two out of three residues occurs between 
the sequences.
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FIGURE 6.13
A comparison of the amino acid sequences of IS. coli
aromatic amino acid AT and E. coli PSAT.
A dot-plot produced by a search for sequence homology (Maizel & Lenk, 
1981; Devereux et al, 1984) between the amino acid sequences of 
IS. coli aromatic amino acid AT (M. Edwards, unpublished results) and
IS. coli PSAT. A dot indicates that a match of two out of three
residues occurs between the sequences.
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CHAPTER 7
GENERAL DISCUSSION AND FUTURE PROSPECTS
7.1 EPSP synthase.
A method for the purification of EPSP synthase from EL coli and 
some properties of the purified enzyme have been described. Milligram 
quantities of homogeneous enzyme can be readily prepared from the 
overproducing strain of EL coli. It is likely that this purification 
procedure could be further "scaled up" in order to obtain even larger 
amounts of EPSP synthase. The complete amino acid sequence of EL coli 
EPSP synthase is available from DNA and protein sequencing studies 
(Duncan etal, 1984b). This combination of protein and DNA studies 
means that the EL coli enzyme is a good choice of monofunctional EPSP 
synthase on which to perform structural studies.
Structural studies which can now be considered include:
(i) The determination of the three-dimensional structure of
EL coli EPSP synthase by X-ray crystallography - this would 
depend on success in obtaining suitable protein crystals;
(ii) the identification of possible active site residues in the 
amino acid sequence - preliminary attempts at chemical 
modification of EL coli EPSP synthase were described in 
chapter 5.
One aim of structural studies on EPSP synthase must be to 
determine how glyphosate interacts with the enzyme. It is interesting 
to note that glyphosate-resistant strains of bacteria have been 
isolated recently. Glyphosate resistance appears to be due either 
to overproduction of EPSP synthase (Rogers et al, 1983; Duncan et al, 
1984a) or to production of a glyphosate-insensitive EPSP synthase 
(Comai et al, 1983; Schulz et al^ , 1984; Sost et al, 1984). The 
glyphosate resistance of a strain of IS. typhimurium has been shown to
be due to a single mutation (Pro— >Ser) in the gene coding for 
EPSP synthase (D. Stalker, Hiatt, W. & Comai, L., unpublished results) 
It would be interesting to examine the effects of such mutations on 
the structural and kinetic properties of EPSP synthase.
The properties of EL coli EPSP synthase described here appear to 
be similar to those of other recently purified, monofunctional EPSP 
synthases (Anton et al, 1983; Mousdale & Coggins, 1984a; Steinrucken & 
Amrhein, 1984a). In particular, the pea seedling.EPSP synthase 
resembles the EL coli enzyme in terms of the purification procedure 
that can be used, subunit structure, values (Table 3.4) and kinetic 
parameters with the exception of the greater sensitivity of the 
IL sativum enzyme to glyphosate inhibition (Mousdale & Coggins, 1984a) 
The readily obtained EL coli enzyme may therefore be used as a model 
for the plant enzyme in studies that require large amounts of protein. 
As yet, only very limited amounts of pea seedling EPSP synthase are 
available (Mousdale & Coggins, 1984a).
The subcellular localisation of P. sativum EPSP synthase has 
recently been reported. EPSP synthase and three other shikimate 
pathway enzyme activities (DAHP synthase and the dehydroquinase/ 
shikimate dehydrogenase complex) appear to be located in chloroplasts 
(Mousdale & Coggins, 1984b).
Monofunctional EL coli EPSP synthase is somewhat smaller than 
the polypeptide carrying EPSP synthase activity (subunit M^ 74,000) 
isolated after limited proteolysis of the N_. crassa arom enzyme 
complex (figure 1.8; Boocock, 1983). It is possible that the M^
74,000 fragment contains some polypeptide chain that is unnecessary 
for EPSP synthase activity. It should be noted that the sum of the 
subunit/

subunit values of the.monofunctional IS. coli shikimate pathway
enzymes 2 to 6 (figure 1.1) equals 163,000 (Table 7.1). This is
similar to the subunit M of 165,000 determined for the N. crassa aromr » — ------------
enzyme complex (Lumsden & Coggins, 1977). This suggests that the 
multifunctional arom complex may have been produced by gene fusion 
events.
7.2 Phosphoserine aminotransferase.
The purification to homogeneity and some properties of PSAT 
from the overproducing strain of E. coli have been described.
Protein chemical studies have demonstrated that the purified enzyme 
is the product of the IS. coli serC gene.
The purification procedure for E. coli PSAT could be: improved.
In particular, the last step, ion-exchange chromatography on the mono-Q 
column was found to be somewhat time-consuming due to the fact that the 
phenyl-Sepharose pool had to be chromatographed in batches because of 
the limited capacity of this column. The preliminary finding that 
IS. coli PSAT is a dimeric enzyme requires further investigation, for 
example, cross-linking experiments should be carried out in order to 
confirm this subunit structure.
The kinetic properties of IS. coli PSAT could be studied further, 
especially with regard to the conversion of serine to OHPyr by this 
enzyme. However, the role of PSAT in pyridoxine biosynthesis is 
likely to become clear only after the biosynthetic pathway for 
pyridoxine has been elucidated.
As with EPSP synthase, large amounts of IS. coli PSAT can be 
readily purified and the complete amino acid sequence of this enzyme 
is known (Duncan, 1984). Structural studies on E. coli PSAT are 
therefore/
therefore possible.. One functional residue of an aminotransferase 
that may be readily identified is the lysine residue to which 
pyridoxal phosphate is covalently bound via an imine linkage. It 
should be possible to identify this residue in IS. coli PSAT by standard 
protein chemical techniques after reduction of the isolated enzyme 
with [3H] NaBH^. Given the lack of obvious sequence homology between 
IS. coli PSAT and other aminotransferases (section 6.7), it would be 
interesting to compare the sequence around the PLP-binding lysine in 
PSAT with corresponding sequences in other aminotransferases, e.g. in 
aspartate aminotransferases where this lysine residue has been 
identified (Kondo et al, 1984).
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